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A B S T R A C T
Background
Fatigue is a common symptom in cancer patients receiving active treatment. There are a limited number of reviews evaluating interven-
tions for fatigue during active treatment, and they are restricted to patients with advanced cancer, or to patients during radiotherapy.
To date there is no systematic review on psychosocial interventions for fatigue during cancer treatment.
Objectives
To evaluate if psychosocial interventions are effective in reducing fatigue in cancer patients receiving active treatment for cancer, and
which types of psychosocial interventions are the most effective.
Search strategy
In September 2008 we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library), PUBMED,
MEDLINE, EMBASE, CINAHL and PsycINFO, and checked the reference lists.
Selection criteria
Randomised controlled trials (RCTs)were includedwhich evaluated psychosocial interventions in adult cancer patients during treatment,
with fatigue as an outcome measure.
Data collection and analysis
Three review authors independently extracted data from the selected studies, and assessed the methodological quality using several
quality rating scales and additional criteria.
Main results
Twenty-seven studies met the inclusion criteria with a total of 3324 participants, and seven studies reported significant effects of the
psychosocial intervention on fatigue. In three studies the effect was maintained at follow-up. The quality of the studies was generally
moderate. Effect sizes varied between 0.17 to 1.07.
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The effectiveness of interventions specific for fatigue was significantly higher (80%) compared to interventions not specific for fatigue
(14%). In five studies the interventions were specifically focused on fatigue, with four being effective. The five interventions were brief,
consisting of three individual sessions, provided by (oncology) nurses. In general, during these interventions participants were educated
about fatigue, were taught in self-care or coping techniques, and learned activity management.
Of the remaining 22 studies only three were effective in reducing fatigue, and these interventions had a more general approach. These
interventions were aimed at psychological distress, mood and physical symptoms, and varied strongly in duration and content.
Authors’ conclusions
There is limited evidence that psychosocial interventions during cancer treatment are effective in reducing fatigue. At present, psychoso-
cial interventions specifically for fatigue are a promising type of intervention. However, there is no solid evidence for the effectiveness of
interventions not specific for fatigue. Most aspects of the included studies were heterogeneous, and therefore it could not be established
which other types of interventions, or elements were essential in reducing fatigue.
P L A I N L A N G U A G E S U M M A R Y
The effect of psychosocial interventions on fatigue during cancer treatment in adults
There is limited evidence that psychosocial interventions are effective in reducing fatigue during active treatment in cancer patients.
Most promising are psychosocial interventions specifically designed to treat fatigue. In general, during these interventions patients were
educated about fatigue, were taught in self-care or coping techniques, and learned to manage their activity. Interventions that did not
focus on fatigue were rarely effective in reducing fatigue.
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B A C K G R O U N D
In recent years the treatment of cancer has changed, as more peo-
ple are treated and an increasing number survive the disease. The
primary focus of treatment for cancer is survival, but alongside this
themanagement of symptoms andquality of life of patients are also
becoming important. Fatigue is one of the symptoms most com-
monly reported by cancer patients and is gaining more recogni-
tion by oncologists. In addition to this scientific knowledge about
fatigue in cancer patients is growing. Fatigue can be described in
terms of perceived energy, mental capacity and psychological sta-
tus (Cella 1998; Portenoy 1999) and is therefore a multidimen-
sional concept. Fatigue is sometimes seen as a continuum, ranging
from tiredness to exhaustion (Ahlberg 2003).
Cancer-related fatigue (CRF) is a term that is frequently used. The
National Comprehensive Cancer Network (NCCN) defines CRF
as a distressing, persistent, subjective sense of physical, emotional
and/or cognitive tiredness or exhaustion, related to cancer or can-
cer treatment that is not proportional to recent activity and inter-
feres with usual functioning (NCCN 2008). Cancer patients can
experience fatigue at different stages, for example, during cancer
treatment or shortly after finishing treatment. Disease-free can-
cer patients can also experience fatigue. The prevalence of fatigue
during cancer treatment ranges from 25% to 99% depending on
the sample and on the type of instrument used to measure fatigue
(Servaes 2002). After successful cancer treatment, fatigue can still
be a problem in up to 38% of cancer survivors and can persist for
many years (Servaes 2002a). It is important to note that the term
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CRF does not make a distinction between fatigue during cancer
treatment, and fatigue after finishing treatment, but covers the
whole period.
Efforts to manage fatigue should first focus on identifying and
treating the comorbidities that may cause it, for example, anaemia
or hypothyroidism. However, often no specific cause for fatigue
can be identified in patients during cancer treatment, other than
the cancer or the treatment itself. In these situations the manage-
ment of fatigue usually involves multiple strategies. The strategies
are often divided into pharmacological and non-pharmacological
interventions.
Minton 2008 reviewed drug therapy for the management of CRF
and concluded that erythropoietin and darbopoetin, drugs that
improve anaemia, are effective in managing CRF in patients who
are anaemic as a result of chemotherapy. However, currently con-
cerns are raised about the safety of these drugs as a series of recent,
randomised placebo-controlled clinical trials reported adverse ef-
fects including enhanced tumour progression and increased mor-
tality (Bennett 2008; Khuri 2007). Methylphenidate was also ef-
fective, but more research is needed to confirm this. No data cur-
rently supports the use of paroxetine or progestational steroids for
treatment of CRF (Minton 2008). This review included studies
that recruited participants at any point of the cancer treatment
spectrum. A Cochrane review is also in progress evaluating drugs
for the treatment of fatigue in palliative care (Radbruch 2007).
There are an increasing number of studies with exercise as a non-
pharmacological intervention for cancer patients. Current litera-
ture suggests that exercise is likely to be beneficial, but the latest
reviews draw conflicting conclusions about the role of exercise on
managing fatigue (Stone 2008). Some reviews concluded that ex-
ercise had a positive effect on fatigue (Conn 2006;McNeely 2006)
while others found no effect of exercise on fatigue (Jacobsen 2007;
Knols 2005; Stevinson 2004). In addition a Cochrane review in-
vestigating exercise for fatigue in cancer patients is also now pub-
lished (Cramp 2008).
All reviews mentioned above were based on studies that included
cancer patients during active treatment and disease-free survivors.
In the review of Ahlberg 2003 a distinction was made between
studies evaluating exercise during cancer treatment and after treat-
ment, and concluded that in all studies the exercise groups had
lower levels of fatigue. Contrary to this, the Cochrane review of
Markes 2006 concluded that exercise had no effect on fatigue in
breast cancer patients during adjuvant therapy.
In recent years more studies have evaluated psychosocial interven-
tions for the management of fatigue. The aim of a psychosocial
intervention is to influence or change cognitions, emotions, be-
haviour, the social environment or a combination of these, with
the ultimate goal to decrease fatigue.
Some reviews have included psychosocial interventions as a sub-
group for managing fatigue in cancer patients and these interven-
tions have been regarded as some of the more promising treat-
ments, but further research was recommended (Lawrence 2004;
Mock 2004). A recent meta-analysis is less positive and concluded
that there is limited support for the clinical use for psychological
interventions for CRF (Jacobsen 2007). However, these reviews
were based on studies that included patients during the whole
spectrum of cancer treatment, as well as disease-free survivors.
There are only a limited number of reviews that evaluated in-
terventions for fatigue in patients who received active treatment.
These reviews were restricted to certain patient groups, for exam-
ple to patients with advanced cancer (Barnes 2002), metastatic
breast cancer (Edwards 2004), or to patients during radiotherapy
(Jacobsen 2003; Jereczek-Fossa 2002).
To date, no systematic review has been published evaluating the
effectiveness of psychosocial interventions for fatigue during can-
cer treatment, which was the goal of this review. In this review
we identified studies that tested the effectiveness of psychosocial
interventions in randomised controlled trials (RCT). First we de-
scribed which psychosocial interventions were effective in reduc-
ing fatigue, and how strong the effects were by using effect sizes.
Secondly, the quality of the studies was evaluated. Finally, themore
promising psychosocial interventions for reducing fatigue during
cancer treatment are discussed.
O B J E C T I V E S
The primary objective was to evaluate if psychosocial interventions
are effective in reducing fatigue in cancer patients receiving active
treatment for cancer.
The secondary objective was to consider which specific types of
psychosocial interventions during cancer treatment are the most
effective in reducing fatigue.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Only RCTs were included in this review. In addition, studies with
small sample sizes (less than ten participants) were excluded, as this
causes a lack of power to demonstrate the effect of an intervention.
This means that when no significant effect of an intervention
is found, this doesn’t necessarily mean that the intervention is
not effective at all. Finding no effect of the intervention can be
explained by the small sample size of the studies. Thus the results
of these studies can be misinterpreted easily.
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Types of participants
Adult (those aged 16 years and above) cancer patients of either sex,
receiving active treatment for cancer, with curative or palliative
intention. This review focused only on patients receiving active
cancer treatment and not on patients who finished cancer treat-
ment. Although some cancer survivors, specifically breast cancer
survivors, continue to receive hormone therapy for several years,
in this review this group of survivors was considered as a group
who finished the active period of receiving cancer treatment.
Types of interventions
A broad range of interventions were considered, such as psy-
chotherapy, psycho-education and also interventions containing
elements such as; education, cognitive restructuring and changing
coping strategies. Interventions focusing on behavioural changes
were included, for example; behavioural therapy, self-help or self-
care. In addition other intervention types such as; support groups,
relaxation, energy conservation, or stress management, and inter-
ventions combining psychosocial elements with physical activity
were included. Both individual and group-focused interventions
were included.
The psychosocial intervention needed to fulfil the following con-
ditions:
• the interventions involved a systematic treatment con-
sisting of a process between the patient and the person
giving the intervention;
• the interventions consisted of at least two contacts be-
tween the patient and the care provider who gave the
intervention;
• during the intervention a care provider gave the patient
some kind of personal feedback concerning the changes
they were trying to achieve, for example, in the first
session a care provider could advise a patient to change
their coping behaviour aiming to reduce fatigue, whilst
discussing the progress of the patient and giving feed-
back on their behaviour in later sessions.
Types of outcome measures
In the included studies, fatigue was at least one of the outcome
measures. Studies were included when fatigue was measured with
a questionnaire specifically designed to evaluate fatigue, or other
instruments used by authors to evaluate fatigue. For example, fa-
tigue was measured as part of a quality of life instrument, with
a visual analogue scale (VAS), or as part of a symptom list and
scored as ‘present’ or ‘absent’.
Search methods for identification of studies
1) Electronic databases
We searched the Cochrane Central Register of Controlled
Trials (CENTRAL) (The Cochrane Library, September 2008),
PUBMED (1950 to September 2008), MEDLINE (1966
to September 2008), EMBASE (1980 to September 2008),
CINAHL (1982 to September 2008) and PsycINFO (1806 to
September 2008).
We identified studies for this review using search strategies based
on the MEDLINE (via OVID) strategy set out in Appendix 1,
which uses a combination of MeSH and free text terms. MeSH
terms were exploded. Terms were searched in the title, abstract,
summary, heading or keywords. We applied the Cochrane Col-
laboration filter for the identification of RCTs, as published in the
Cochrane Handbook for Systematic Reviews of Interventions (
Higgins 2008). We adjusted the search strategy appropriately for
each database searched.
2) Reference search
We checked the reference lists of relevant articles for additional
studies, and applied backward and forward searching to the rele-
vant articles.
3) Journals
When no digital articles are available, we hand searched the jour-
nals.
4) Communications
We contacted authors of several studies to require additional in-
formation.
5) Ongoing studies
We checked The Australian New Zealand Clinical Trials Registry,
the ClinicalTrials.gov registry, the ISRCT register, UMINClinical
Trials Registry, and the Dutch Trial Register, for ongoing studies.
We searched each register for the keywords ’cancer’ and ’fatigue’,
and selected studies that were currently recruiting participants.
There was no language restriction on studies.
Data collection and analysis
Selection of trials
One review author (MMG) screened titles and abstracts and elim-
inated those clearly not relevant to this review. When the title
and abstract did not provide all the information concerning the
criteria, full paper copies were retrieved and screened. Authors of
studies were contacted when additional information was required
to assess if the studies met the criteria for inclusion. Three review
authors (MMG, MG and GB) screened the remaining studies for
their eligibility and discussed in accordance with the above defined
criteria, if the studies were included or excluded. Disagreement
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about the selection of a trial was resolved by consensus. The re-
view authors were already familiar with some of the studies, and
therefore the relevant studies were not blinded for assessment.
Quality assessment
Three review authors (MMG, MG and GB) independently as-
sessed themethodological quality of the selected studies. TheRCTs
were evaluated using a Quality Rating Scale. This scale contained
all the criteria of the Oxford Quality Scale (Jadad 1996), the Del-
phi list (Verhagen1998) and additional criteria listed by van Tulder
1997. The following aspects of the selected studies were scored to
evaluate the methodological quality:
• random assignment;
• losses to follow-up;
• blind analysis;
• intention-to-treat analysis;
• participants adherence;
• adverse effects of the intervention;
• eligibility criteria;
• follow-up measurements;
• power calculation;
• possible differences between the treatment group and
the control group, and in the timing of the assessments;
• concealed allocation;
• contamination.
Concealment of allocation was evaluated using the criteria de-
fined in The Cochrane Handbook (Higgins 2008). When noth-
ing was described about concealment of allocation in the stud-
ies, concealed allocation was evaluated as ‘unclear’. To investigate
the effectiveness of an intervention it is important to minimize
contamination. Contamination means that patients in the control
group get informed about the intervention and its content, and
subsequently use this information. When this happens the effect
of the intervention itself is harder to demonstrate. To minimize
contamination it is advisable to avoid contact between patients in
the control condition, and care providers giving the intervention,
or other staff informed about the intervention.
Additional aspects were scored to evaluate the quality of the inter-
vention:
• how many care providers gave the intervention;
• if care providers were trained;
• if care providers were supervised;
• if an intervention protocol was used;
• if an integrity check was described.
In most quality rating scales blinding is evaluated on several lev-
els, such as blinding of patients and care providers. These scales
are often used to test the quality of placebo-controlled medication
studies. However, the nature of RCTs testing psychosocial inter-
ventions is different. In these trials it is nearly impossible to blind
the patients to the intervention they were assigned to. In addition
it is also impossible to blind the care providers to the intervention
they are giving to the patients. Thus, blinding of patients and care
providers were not scored in the Quality Rating Scale.
The three review authors met to discuss all items of the Quality
Rating Scale of the studies, and to reach a final quality score by
consensus. The total score of the Quality Rating Scale varied be-
tween one and 25 and was divided into three categories. When
the total score was between one and nine, the quality was rated as
poor, when between ten and 17 as moderate, and when between
18 and 25 as good.
Data extraction
Three review authors (MMG, MG and GB) independently ex-
tracted data from the selected studies using data extraction forms.
The data extraction form was designed using listed criteria de-
scribed by van Tulder 1997, and a scale to evaluate RCTs devel-
oped by the EBRO-forum (CBO 2002), and was expanded with
necessary informationon the psychosocial interventions to be eval-
uated. Any disagreement was resolved through consensus.
From each selected study the following data was extracted:
Patient characteristics:
• Demographic characteristics such as age and gender.
• Disease characteristics such as type of cancer, stage of
cancer, types and duration of treatment.
Intervention characteristics:
• Duration of the intervention, total number of sessions
and duration of each session.
• The nature and content of the psychosocial interven-
tion.
• The number of care providers and the profession.
• Duration and nature of training and supervision given
to the care providers.
• Patient compliance and contamination.
Information on statistics:
• Number of participants in each arm.
• Durationof short-term follow-up and, if available, long-
term follow-up.
• Instruments used, key outcomes and description of
missing data.
Data synthesis and effect of psychosocial
interventions
A narrative overview of the included RCTs was provided in this
review. We assessed which interventions during cancer treatment
were effective in reducing fatigue, and described explanations for
the effectiveness where possible. To determine the magnitude of
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the effect, effect sizes were calculated of the studies that were ef-
fective in reducing fatigue. The size of the effect is calculated in a
standardized way, and therefore the effect sizes across the various
studies can be compared. The effect sizes were calculated by using
the means and standard deviations of two groups (experimental
group and control group) of the post-intervention or follow-up
measurement, in the following way:
Effect size = M1 - M2/σpooled
where σpooled =
√
[(σ 1²+ σ 2²)/2]
As the characteristics of the included studies, the instruments, and
the interventions were very diverse, we concluded that a meta-
analysis or a subgroup analysis was not sensible or appropriate.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Excluded studies
The search of the electronic databases retrieved 2210 publications.
After eliminating the duplicates 1753 publications were identified
for further consideration. After screening the titles and electronic
available abstracts 1668 publications were excluded. Reasons for
excluding publications were the following:
• studieswere no intervention studies, for example studies
were reviews, or comments;
• studies evaluated no psychosocial interventions, for ex-
ample medical treatments, exercise, or massage;
• studies were no RCTs, for example studies did not have
a control group, or participants were not randomised;
• studies did not focus on cancer patients or only a part
of the sample were cancer patients;
• studies evaluated interventions in cancer patients after
finishing cancer treatment;
• fatigue was not assessed as an outcome measure.
After this initial screening, the full-text articles were retrieved of
the remaining 85 potential studies. From these full-text articles
56 studies were excluded leaving 29 studies to review. These 56
studies were excluded for the following reasons; 15 studies were
excluded because the interventions were given to participants af-
ter finishing cancer treatment. One study was excluded because
most participants did not receive cancer treatment during the in-
tervention. Five studies did not describe if participants received
cancer treatment during the intervention. One study focused on
participants receiving colorectal surgery and did not only include
cancer patients, but also patients with other types of diseases. Six
studies were not RCTs. Two studies had less than ten participants
in each condition. In four studies fatigue was not measured and
three studies did not describe separate results on fatigue. Nine-
teen studies identified did not include psychosocial interventions.
In two studies the intervention was mainly focused on changing
exercise behaviour. In three studies nutritional behaviour was the
focus of the intervention and one focused on medication. In 13
studies the interventions were not psychosocial interventions ac-
cording to our definition described in ’Types of intervention’. The
interventions did not consist of a systematic process between the
patient and the person giving the intervention. The excluded stud-
ies are described in more detail in the ’Characteristics of excluded
studies’ table.
Ongoing studies
The search for ongoing studies found eight RCTs that are cur-
rently recruiting participants. Three of these studies are evaluating
different types of yoga intervention (Cohen 2007a; Cohen 2007b;
Oh 2008b). Purcell 2008 is evaluating a group education and sup-
port intervention, and Savard 2008 a self help treatment for in-
somnia. Two studies are evaluating two interventions compared
to usual care. Cohen 2004a is evaluating mindfulness relaxation,
and music relaxation. Goedendorp 2005 is evaluating cognitive
behaviour therapy and a nursing intervention. Cohen 2006 is also
evaluating a cognitive behaviour intervention. The ongoing stud-
ies are described in more detail in the ’Characteristics of ongoing
studies’.
Included studies
Two remarks should bemade with regards to the 29 included stud-
ies. In the Sandgren 2003 study the immediate effects of the inter-
vention are described whereas the duplicate study Sandgren 2007
includes the follow-up. Goodwin 2001 and it’s duplicate study
Bordeleau 2003 described the effects of the same intervention, but
presented results on different outcome measures. Therefore these
29 publications were evaluated as 27 separate included studies.
Participants
Disease characteristics
Amajority of the studies, 13, focused on patients with one type of
malignancy, mainly patients with breast cancer. In eleven studies
participants were patients with breast cancer, however, with dif-
ferent stages of cancer. Three studies included breast cancer pa-
tients with stages I-II (Cohen 2007; Sandgren 2000; Yates 2005).
Sandgren 2003 and Moadel 2007 included patients with stages I-
III, and Gaston-Johansson 2000 included patients with stages II-
IV. Two studies focused on patients with other types of cancer,
such as prostate cancer (Berglund 2007), or malignant melanoma
(Fawzy 1995). Six studies included only metastatic cancer patients
(Classen 2001; de Moor 2002; Edelman 1999; Goodwin 2001;
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Savard 2006; Spiegel 1981). Five of these studies included pa-
tients with metastatic breast cancer (Classen 2001; Edelman 1999;
Goodwin 2001; Savard 2006; Spiegel 1981), and one; patients
with metastatic renal cell carcinoma (de Moor 2002).
The remaining studies included cancer patients with more than
one diagnosis. Two studies focused on patients with two types of
cancer. The first study included patients being treated for prostate
or bladder cancer (Faithfull 2001). The second study included
patients receiving treatment for gastric or colon cancer (Godino
2006). Rawl 2002 included patients with three different types of
cancer: breast, colorectal and lung cancer. Ten studies focused on
cancer patients in general and included patients with several types
of cancer, such as lymphoma’s, breast, lung, colorectal, prostate,
gynaecologic, testicular cancer, and other solid tumours (Armes
2007; Barsevick 2004; Brown 2006; Cunningham 1989; Decker
1992; de Wit 1997; Given 2002; Oh 2008; Ream 2006), how-
ever, one study excluded patients with abdominal cancer (Forester
1985).
One study explicitly described that patients were treatedwith cura-
tive intent (Barsevick 2004), and Brown 2006 focused on patients
with advanced cancer. Eleven studies included cancer patients with
various stages of cancer, with or without metastasis (Armes 2007;
Cunningham 1989; Decker 1992; de Wit 1997; Faithfull 2001;
Forester 1985; Given 2002; Godino 2006; Oh 2008; Rawl 2002;
Ream 2006).
Cancer treatment
All 27 included studies described results of interventions given
to patients during cancer treatment. In 15 studies all patients
were receiving cancer treatment during the intervention (Armes
2007; Barsevick 2004; Brown 2006; Cohen 2007; Decker 1992;
de Moor 2002; Faithfull 2001; Forester 1985; Gaston-Johansson
2000; Given 2002; Godino 2006; Sandgren 2003; Rawl 2002;
Ream 2006; Yates 2005). In ten studies most, but not all, patients
were receiving active cancer treatment during the intervention (
Berglund 2007; Classen 2001; Cunningham 1989; de Wit 1997;
Edelman 1999; Fawzy 1995; Goodwin 2001; Moadel 2007; Oh
2008; Sandgren 2000). The percentage of patients receiving ac-
tive treatment during the intervention varied from at least 44%
(Sandgren 2000) to 91% (de Wit 1997). Edelman 1999, Savard
2006 and Spiegel 1981 did not describe how many patients ac-
tually received cancer treatment during the intervention. How-
ever, these studies focused on patients with metastatic cancer, and
therefore it is expected that these patients would have received
treatment sometime during the intervention.
In most studies the interventions were given to patients receiv-
ing chemotherapy only (Armes 2007; Given 2002; Godino 2006;
Rawl 2002; Ream 2006; Yates 2005), or radiotherapy only (Brown
2006; Decker 1992; Faithfull 2001; Forester 1985). Four stud-
ies included participants receiving chemotherapy or radiotherapy
(Barsevick 2004; Cohen 2007; Sandgren 2000), or chemother-
apy or hormone therapy (Classen 2001). Five studies included
participants with several treatment regimes. One study included
participants who had surgery, radiotherapy or hormone ther-
apy (Berglund 2007). Five studies included participants receiving
chemotherapy, radiotherapy or hormone therapy (Cunningham
1989; Goodwin 2001; Sandgren 2003), or additionally surgery
or other treatment (de Wit 1997; Moadel 2007). In one study
some participants received chemotherapy, but it is unclear if par-
ticipants also received other types of treatment (Oh 2008). Three
studies focused on other treatments (Fawzy 1995; de Moor 2002;
Gaston-Johansson 2000). The first study included patients receiv-
ing immunotherapy (Fawzy 1995). The second study focused on
patients receiving nephrectomy and vaccine treatment (de Moor
2002) and the third study included patients receiving bone mar-
row transplantation (Gaston-Johansson 2000).
Other criteria for inclusion
In two studies the participant sample was strikingly different than
the other studies. deWit 1997 included only participantswith can-
cer related pain, and Savard 2006 focused on depressed metastatic
breast cancer patients.
Two studies described inclusion criteria for fatigue. Armes 2007
explicitly described that cancer patients with significant fatigue
were included, and Given 2002 included patients reporting both
fatigue and pain at baseline. As patients were included during
chemotherapy, it is expected that themajority of the patientswould
experience symptoms at time of accrual.
Most studies described additional exclusion criteria. Participants
were excluded for several reasons. Some reasons were cancer or
treatment related. Three studies excluded cancer patients with
previous (Classen 2001; Fawzy 1995) or other cancer (Berglund
2007). Six studies excluded patients who received previous cancer
treatment (Godino 2006), such as chemotherapy (de Moor 2002;
Ream 2006), radiotherapy (Decker 1992), cytokine treatment (
Armes 2007), or immunotherapy (de Moor 2002). One study ex-
cluded patients if their treatment plan included stem cell trans-
plantation, interleukins, interferons, or tumour necrosis factor (
Barsevick 2004).
Other additional criteria were also described. Most studies ex-
cluded cancer patients with other comorbidities (Armes 2007;
Barsevick 2004; Berglund 2007; Classen 2001; de Moor 2002;
Edelman 1999; Godino 2006; Goodwin 2001; Oh 2008;
Sandgren 2003), or current or a history of psychiatric illnesses (
Armes 2007; Berglund 2007; Brown 2006; Cohen 2007; Decker
1992; Decker 1992; Fawzy 1995; Godino 2006; Goodwin 2001;
Oh 2008; Ream 2006; Savard 2006). Eight studies excluded can-
cer patients involved in intervention studies (Barsevick 2004;
Brown 2006), or other types of care programs (Savard 2006), such
as support groups (Berglund 2007; Goodwin 2001), attending
yoga (Moadel 2007) or medical qigong (Oh 2008), or receiving
psychotherapy (Armes 2007). Six studies did not describe addi-
tional criteria (Cunningham 1989; Faithfull 2001; Ream 2006;
Sandgren 2000; Spiegel 1981; Yates 2005).
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Interventions
Studies were only included in this review if participants received
the intervention during cancer treatment.
In most studies the intervention was started during cancer treat-
ment, although it often remained unclear at what stage of cancer
treatment the interventions ended. Of the studies that evaluated
short interventions (four weeks or less) it is likely that participants
continued with cancer treatment after the intervention (Barsevick
2004; Brown 2006; de Moor 2002; Yates 2005). When the dura-
tion of the intervention was longer it remained unclear how many
participants continued with cancer treatment after the interven-
tion. Only four studies described explicitly at what stage of cancer
treatment the intervention ended. In Faithfull 2001 the interven-
tion started at the beginning of cancer treatment and ended at
the end of the treatment. In three studies the intervention con-
tinued after participants finished cancer treatment (Forester 1985;
Gaston-Johansson 2000; Godino 2006).
Format
In most studies the intervention was administered by nurses
(Armes 2007; Barsevick 2004; de Wit 1997; Faithfull 2001;
Fawzy 1995; Given 2002; Godino 2006; Rawl 2002; Ream 2006;
Sandgren 2003; Yates 2005). In the study of Oh 2008 an expe-
rienced instructor gave medical qigong. In the study of Moadel
2007 the yoga instructor was also an oncologist. In the remain-
ing studies the intervention was administered by social work-
ers (Cohen 2007; Gaston-Johansson 2000), (psycho)therapists (
Edelman 1999; Forester 1985), psychologists (Savard 2006), or
graduate students (Cunningham 1989; Decker 1992; Sandgren
2000). In five studies the intervention was multidisciplinary (
Berglund 2007; Brown 2006; Classen 2001; Goodwin 2001;
Spiegel 1981). In seven studies there was one care provider giving
the intervention (Armes 2007; Cohen 2007; Cunningham 1989;
Forester 1985; Moadel 2007; Oh 2008; Rawl 2002). In three
studies it was unclear how many care providers gave the interven-
tion (Faithfull 2001; Fawzy 1995; Gaston-Johansson 2000), but
it may have been only one. In all other studies more than one care
provider gave the intervention.
In ten studies the intervention was given in groups (Berglund
2007; Brown 2006; Classen 2001; Cohen 2007; Cunningham
1989; Edelman 1999; Goodwin 2001; Moadel 2007; Oh 2008;
Spiegel 1981), in the remaining studies the intervention was given
individually. The individual sessions were mostly face-to-face, but
seven were exceptions. In the studies of Sandgren (Sandgren 2000;
Sandgren 2003) and Barsevick 2004 the participants received only
telephone sessions. Three studies combined face-to-face contact
and telephone calls in the intervention (deWit 1997; Given 2002;
Yates 2005). In one study participants received individual writing
instructions, for several occasions (de Moor 2002). The instruc-
tions stimulated participants to write about their thoughts, feel-
ings and consequences on their lives. We decided to include this
study as change of cognitions and behaviour were the focus of the
intervention.
In 14 studies additional information materials were given to the
participants (Armes 2007; Brown 2006; Classen 2001; Cohen
2007; Cunningham 1989; de Wit 1997; Decker 1992; Edelman
1999; Faithfull 2001; Gaston-Johansson 2000; Godino 2006;
Moadel 2007; Oh 2008; Yates 2005). In eight studies participants
received written information (Armes 2007; Brown 2006; de Wit
1997; Edelman 1999; Faithfull 2001; Godino 2006; Oh 2008;
Yates 2005). In one study participants received audiotapes (Moadel
2007), and in five studies participants received both written in-
formation and audiotapes (Cohen 2007; Cunningham 1989;
Decker 1992; Gaston-Johansson 2000) and additional videotapes
(Classen 2001).
Duration
The number of sessions was described in 22 studies, but there was
a lot of variation. Among these studies the number of sessions
varied from two to 12, with a median of six sessions. In two studies
the number of sessions was not fixed for participants (Moadel
2007; Oh 2008). In the remaining three studies the intervention
consisted of weekly 90 minute sessions, for the duration of at least
one year, but the actual number of sessions was not given. The
number of sessions could be estimated to be around 50 (Classen
2001; Goodwin 2001; Spiegel 1981).
Four studies failed to describe the duration of each session (
Edelman 1999; Gaston-Johansson 2000; Godino 2006; Ream
2006). Among the remaining 23 studies the duration of the ses-
sions varied from ten minutes to three hours. The most common
duration was 30 minutes for individual sessions and 90 minutes
for group sessions.
The duration of the full interventionwas described in 20 studies or
could be estimated. The total duration of the interventions varied
from two weeks (Yates 2005) to 20 weeks (Edelman 1999; Given
2002), with three exceptions having a duration of at least one year
(Classen 2001; Goodwin 2001; Spiegel 1981). From six studies
the actual length of the intervention was not clear, but depended
on the cancer treatment participants had received. For example the
sessions took place on specific points in patients’ treatment regimes
(Faithfull 2001; Gaston-Johansson 2000; Godino 2006; Ream
2006), took place during patients’ clinic visits (Fawzy 1995), or
dependedon the durationof the hospital admission (de Wit 1997).
One study did not describe the total length of the intervention (
Decker 1992).
Content
In only five studies the intervention was specifically focused on
fatigue (Armes 2007; Barsevick 2004; Godino 2006; Ream 2006;
Yates 2005). All the other interventions focused on other aspects.
Eight interventions aimed to influence depression (Savard 2006),
depression and anxiety (Berglund 2007), or mood states in general
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(Classen 2001; Cunningham 1989; de Moor 2002; Decker 1992;
Edelman 1999; Spiegel 1981). Some interventions focused on
symptoms, such as pain (deWit 1997), or on symptoms and side-
effects in general (Cohen 2007; Faithfull 2001; Forester 1985;
Gaston-Johansson 2000; Given 2002; Rawl 2002). Interventions
also focused on distress (Classen 2001; Cohen 2007; Cunningham
1989; deMoor 2002; Fawzy 1995; Forester 1985; Sandgren 2000;
Sandgren 2003) and quality of life (Berglund 2007; Brown 2006;
Faithfull 2001;Goodwin 2001;Moadel 2007;Oh2008; Sandgren
2000).
The elements of the intervention varied among the studies. Some
interventions were based on one or two elements, while others
used multiple techniques. Four studies focused on the expression
of emotions (de Moor 2002; Sandgren 2003), on providing social
support (Spiegel 1981), or a combination of these two (Goodwin
2001). Yoga was evaluated in two studies, with elements such as
meditation, and physical stretching. Yoga also falls within comple-
mentary medicine, but as general discussion and relaxation were
also parts of the intervention, it was decided to include these stud-
ies (Moadel 2007; Oh 2008). All other studies used a combination
of several elements in the intervention. Teaching, giving patients
information and education on cancer and treatment is often used
as one of the elements. In two studies exercise was actually per-
formed (Berglund 2007; Brown 2006), but activities were more
often one of the topics, for example activity management, or en-
ergy conservation. Relaxation or guided imagery were sometimes
used as techniques to manage stress. Problem solving or teaching
patients coping strategies were also elements of several interven-
tions. In four studies cognitive (behavioural) therapy was the in-
tervention (Cohen 2007; Edelman 1999; Savard 2006), or psy-
chotherapy (Forester 1985).
Control group
In 18 studies participants in the control group did not receive the
intervention, but received standard care and standard information
(Armes 2007; Berglund 2007; Brown 2006; Cohen 2007; de Wit
1997; Decker 1992; Edelman 1999; Fawzy 1995; Forester 1985;
Gaston-Johansson 2000; Given 2002; Godino 2006; Goodwin
2001; Oh 2008; Rawl 2002; Ream 2006; Sandgren 2000;
Sandgren 2003). In the studies of Savard 2006 and Moadel 2007
participants in the control group were assigned to a waiting list.
One study did not specify the control group (Spiegel 1981). In six
studies the control condition involved more than standard care.
In the study of Classen 2001 participants were provided with self-
directed education materials. In four studies participants in the
control group received an intervention with the same number and
duration of sessions, but received different information. In the first
study the control condition comprised supportive discussion alone
(Cunningham 1989). In the second study participants in the con-
trol group received information on nutrition (Barsevick 2004). In
the third study the control condition was a ’neutral writing’ con-
dition (de Moor 2002). In the fourth study participants received
general information on living with cancer (Yates 2005). In one
study participants in the control group hadmoremoments of con-
tact than in the intervention group (Faithfull 2001). Participants
in the control group received routine ten minute weekly appoint-
ments for patients with bladder cancer, or ten minute two-weekly
appointments for patients with prostate cancer, led by physicians.
Outcomes
Studies were only included when they were RCTs. Thus, all the
studies had a baseline assessment and a post-intervention assess-
ment. However, the total number of assessments varied between
two and six assessments, with a median of three. Studies with
more than two measurements, also assessed participants during
the intervention, or had a follow-up measurement. Twelve studies
had one or more follow-up measurements (Armes 2007; Barsevick
2004; Cohen 2007; Cunningham 1989; de Moor 2002; de Wit
1997; Edelman1999; Fawzy 1995; Forester 1985; Sandgren 2000;
Sandgren 2003; Yates 2005), and ten studies assessed participants
once or more during the intervention (Berglund 2007; Classen
2001; Edelman 1999; Forester 1985; Gaston-Johansson 2000;
Given 2002; Godino 2006; Goodwin 2001; Rawl 2002; Spiegel
1981).
The timing of the measurements varied a lot across the studies. In
most studies participants were assessed immediately or within a
few days after the intervention was completed. In two studies the
time between the end of the intervention and the assessment of
participants was longer; one month (Rawl 2002) and six weeks (
Fawzy 1995) after the intervention. The actual time between the
end of the intervention and the assessment was not obvious in five
studies (Armes 2007; Barsevick 2004; Faithfull 2001; Sandgren
2003; Yates 2005). In two of these studies the actual time between
the end of the intervention and the follow-up assessment was also
unclear (Barsevick 2004; Faithfull 2001). In Barsevick 2004 and
Yates 2005 the post- and follow-up assessment depended on the
treatment regimes, radiotherapy or chemotherapy. Five studies had
a short period between the post-intervention assessment and the
follow-up, of four weeks or less (Armes 2007; Cunningham 1989;
de Moor 2002; de Wit 1997; Forester 1985). Three of these five
studies had additional follow-up measurements at eight weeks (de
Wit 1997), at six, eight, and ten weeks (de Moor 2002), and nine
months after recruitment (Armes 2007). In five other studies the
time between post-intervention and follow-up was longer vary-
ing between three to eight months (Cohen 2007; Edelman 1999;
Fawzy 1995; Sandgren 2000; Sandgren 2003).
Five studies explicitly described that the post-intervention assess-
ment took place after participants finished their cancer treatments
(Armes 2007; de Wit 1997; Forester 1985; Gaston-Johansson
2000; Godino 2006), and three of these studies also had a follow-
up assessment (Armes 2007; de Wit 1997; Forester 1985). In two
studies it was described that part of the participants finished cancer
treatment at the time of follow-up measurement (Barsevick 2004;
Yates 2005).
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Most studies used one instrument to measure fatigue, but six stud-
ies used two to four instruments (Armes 2007; Barsevick 2004;
Brown 2006; Faithfull 2001; Goodwin 2001; Yates 2005) (see
Table 1 ‘Outcomes’). Five instruments were used in multiple tri-
als. The most frequently used instrument was the POMS sub-
scale fatigue/inertia, and was used in 12 studies to measure fa-
tigue (Barsevick 2004; Brown 2006; Classen 2001; Cunningham
1989; de Moor 2002; Decker 1992; Edelman 1999; Fawzy 1995;
Goodwin 2001; Sandgren 2000; Sandgren 2003; Spiegel 1981).
The VAS was used in five studies (Armes 2007; Brown 2006;
Faithfull 2001; Gaston-Johansson 2000; Ream 2006) and the
EORTC QLQ-C30 (Armes 2007; Berglund 2007; de Wit 1997;
Faithfull 2001; Goodwin 2001; Oh 2008) was used in six studies.
The FACT-F (Godino 2006; Yates 2005) and the MFI (Armes
2007; Savard 2006) were used in two studies. All other instru-
ments were only used in a single study.
Author and year Instruments used to measure fatigue number of instruments used to measure fatigue
Armes 2007 Visual Analogue Scale (VAS-f ) of global fatigue.
European Organisation for Research and Treat-
ment of Cancer Quality of Life Questionnaire C30
(EORTC QLQ-C30), sub-scale fatigue. Multidi-
mensional Fatigue Inventory (MFI).
3
Barsevick 2004 Short Form of the Profile of Mood States (POMS),
sub-scale Fatigue. Schwartz Cancer Fatigue Scale
(SCFS). General Fatigue Scale (GFS).
3
Berglund 2007 European Organisation for Research and Treat-
ment of Cancer Quality of Life Questionnaire C30
(EORTC QLQ-C30), sub-scale fatigue.
1
Brown 2006 Single item Linear Analogue Self Assessment
(LASA). Profile of Mood States (POMS), Fatigue-
Inertia sub-scale. STAI question 26, Symptom Dis-
tress Scale (SDS) fatigue question.
4
Classen 2001 Profile of Mood States (POMS), Fatigue-Inertia
sub-scale.
1
Cohen 2007 Fatigue Symptom Inventory (FSI). 1
Cunningham 1989 Profile of Mood States (POMS), Fatigue-Inertia
sub-scale.
1
(Continued...)
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Decker 1992 Profile of Mood States (POMS), Fatigue-Inertia
sub-scale.
1
de Moor 2002 Profile of Mood States (POMS), Fatigue-Inertia
sub-scale.
1
de Wit 1997 European Organisation for Research and Treat-
ment of Cancer Quality of Life Questionnaire C30
(EORTC QLQ-C30), sub-scale fatigue.
1
Edelman 1999 Profile of Mood States (POMS), Fatigue-Inertia
sub-scale.
1
Faithfull 2001 Visual Analogue Scale (VAS). European Organisa-
tion for Research and Treatment of Cancer Quality
of Life Questionnaire C30 (EORTC QLQ-C30),
sub-scale fatigue.
2
Fawzy 1995 Profile of Mood States (POMS), Fatigue-Inertia
sub-scale.
1
Forester 1985 Schedule of Affective Disorders and Schizophrenia
(SADS), item Fatigue.
1
Gaston-Johansson 2000 Visual Analogue Scale (VAS). 1
Given 2002 Symptom Experience Scale (SES), item Fatigue. 1
Godino 2006 Functional Assessment of Cancer Therapy Fatigue
(FACT-F).
1
Goodwin 2001 Profile of Mood States (POMS), Fatigue-Inertia
sub-scale. European Organisation for Research and
Treatment of Cancer Quality of Life Questionnaire
C30 (EORTC QLQ-C30), sub-scale fatigue.
2
Moadel 2007 Functional Assessment of Chronic Ilness Therapy -
Fatigue (FACIT-F).
1
Oh 2008 European Organisation for Research and Treat-
ment of Cancer Quality of Life Questionnaire C30
(EORTC QLQ-C30), sub-scale fatigue.
1
(Continued...)
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Rawl 2002 SF-36 Vitality. 1
Ream 2006 Visual Analogue Scale (VAS), SF-36 sub-scale vital-
ity.
2
Sandgren 2000 Profile of Mood States (POMS), Fatigue sub-scale. 1
Sandgren 2003 Profile of Mood States (POMS), Fatigue-Inertia
sub-scale.
1
Savard 2006 Multidimensional Fatigue Inventory (MFI). 1
Spiegel 1981 Profile of Mood States (POMS), Fatigue sub-scale. 1
Yates 2005 Revised Piper Fatigue Scale (PFS). Functional As-
sessment of Cancer Therapy Fatigue (FACT-F).
Four 11-point numeric fatigue rating scales (NFRS)
assessing levels of fatigue at worst, best, and average
in the past week, and currently.
6
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A minority of the studies, only five, used specific questionnaires
designed to measure fatigue, such as the MFI, SCFS, GFS, FSI,
PFS. The most frequently used instruments were used to measure
mood states, or quality of life. Fatigue in these instruments was
measured with a sub-scale, or with only one item.
Other study characteristics
The sample size of the 27 included studies varied between 30 and
396, with a total of 3324 participants. Most studies described the
sample at randomisation. Five studies described the number of
participants at baseline (Edelman 1999; Yates 2005), or used for
analysis (Cohen 2007; Decker 1992; Gaston-Johansson 2000).
The mean sample size was 123 (standard deviation (s.d.) 87).
Twelve studies had a sample size smaller than 100 (Armes 2007;
Cohen 2007; Cunningham 1989; de Moor 2002; Decker 1992;
Edelman 1999; Fawzy 1995; Godino 2006; Oh 2008; Sandgren
2000; Savard 2006; Spiegel 1981), and ten studies between 100
and 200 (Brown 2006; Classen 2001; Faithfull 2001; Forester
1985; Gaston-Johansson 2000; Given 2002; Moadel 2007; Rawl
2002; Ream 2006; Yates 2005). Five studies had a larger sample
than 200 (Barsevick 2004; Berglund2007; deWit 1997;Goodwin
2001; Sandgren 2003).
Methodological Quality
The results of the methodological quality assessment are described
in the Tables of Quality Assessment (Table 2; Table 3; Table 4). A
majority of the studies scored one or two on the Oxford Quality
Scale (Jadad 1996) within the range of one to five. Only three
studies scored three (Rawl 2002; Ream 2006; Yates 2005). On the
Delphi List (Verhagen 1998) seven studies scored above three (
Barsevick 2004; Cohen 2007; Gaston-Johansson 2000; Goodwin
2001; Ream 2006; Sandgren 2003; Yates 2005) and none of these
were published before the year 2000. Looking at the scores on
internal validity as suggested by van Tulder 1997, only one study
had a good evaluation with a score of five (Yates 2005). All other
studies scored lower than five.
Scales Armes 2007 Barsevick
2004
Berglund
2007
Brown 2006 Classen
2001
Cohen 2007
Cunningham
1989
Decker
1992
randomisation 1 1 1 1 1 1 1 1
concealment
of allocation
0 0 0 0 0 0 0 0
0 0 0 0 0 1 0 1
(Continued...)
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(...Continue)
blinded out-
come asses-
sor
power calcu-
lation
1 0 0 0 0 0 0 0
intention to
treat
0 1 0 0 0 0 0 0
group
similarity at
baseline
0 1 1 0 1 1 1 0
specified el-
igibility cri-
teria
1 1 1 1 1 1 0 1
drop-out 1 0 1 0 1 0 1 0
selective lost
to follow-up
0 1 0 0 0 0 0 1
co-interven-
tion avoided
1 1 1 1 1 1 1 1
compliance 1 1 0 1 1 1 0 0
relevant
measures
1 1 1 1 1 1 1 1
timing
assessments
1 1 0 1 1 0 0 1
equally
treatment
1 1 1 0 1 1 1 1
contamination0 0 0 0 0 0 1 0
protocol 1 1 0 1 1 1 1 1
training 1 1 0 1 0 0 0 0
1 1 0 0 0 0 0 0
(Continued...)
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integrity
check
adverse
effects
0 0 0 0 0 0 0 0
sample size 1 0 0 0 1 1 1 0
missing val-
ues
0 1 0 0 0 0 0 0
standard de-
viation
1 1 0 0 0 1 0 1
desc. of in-
dex & con-
trol
intervention
1 1 1 1 1 1 1 1
long
term follow-
up measure-
ment
1 1 1 1 0 1 1 1
supervision 1 1 0 0 1 0 0 1
Oxford
Quality
Scale (Jadad
1996)
2 1 2 1 2 1 2 1
Delphi list (
Verhagen
1998)
2,5 3,5 2,5 1,5 2,5 3,5 1,5 2,5
Internal Va-
lidity
(van Tulder
1997)
4,5 4,5 3,5 3,5 4,5 4,5 3,5 3,5
Total (25) 17 18 9 10 13 13 11 13
Oxford Quality Scale (Jadad 1996): randomisation, concealed allocation, drop-out (0-3).
Delphi list (Verhagen 1998): randomisation (0,5 points), concealed allocation (0,5 points), blinded outcome assessor, power calculation,
intention to treat, group similarity at baseline, specified eligibility criteria (0-6).
Internal validity (van Tulder 1997): randomisation, concealed allocation, blinded outcome assessor, intention to treat, drop-out, co-
intervention avoided, compliance, timing assessments. (0-8)
Yes= 1, No= 0, Not enough information to answer this question= 0
desc. = description
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Scales de Moor
2002
de Wit
1997
Edelman
1999
Faithfull
2001
Fawzy
1995
Forester
1985
Gaston-
Johansson
2000
Given
2002
Godino
2006
randomisation1 1 1 1 1 1 1 1 1
concealment
of
allocation
0 0 0 0 0 0 0 0 0
blinded
outcome
assessor
0 0 0 0 0 0 0 0 0
power cal-
culation
0 0 0 1 0 0 1 0 0
intention
to treat
0 0 0 0 0 0 0 0 0
group sim-
ilarity at
baseline
1 1 1 0 1 1 1 1 0
specified
eligibility
criteria
1 1 1 1 1 1 1 1 1
drop-out 1 1 1 0 0 0 0 0 1
selective
lost to fol-
low-up
0 -1* 0 0 0 0 0 1 0
co-inter-
vention
avoided
1 1 1 1 1 1 1 1 1
compliance 1 1 0 0 0 0 0 0 0
relevant
measures
1 1 1 1 1 1 1 1 1
timing as-
sessments
1 1 1 1 0 1 1 0 1
(Continued...)
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(...Continue)
equally
treatment
1 1 1 1 1 1 1 1 1
contamination0 0 0 0 0 0 0 0 0
protocol 1 1 1 0 1 0 1 1 1
training 0 1 0 0 0 0 0 1 1
integrity
check
0 0 0 0 0 0 0 0 0
adverse ef-
fects
0 0 0 0 0 0 0 0 0
sample size 0 1 1 1 0 1 1 1 1
missing
values
0 0 0 0 0 0 0 0 0
standard
deviation
0 1 0 0 1 0 1 0 1
desc. of in-
dex & con-
trol inter-
vention
1 1 1 1 1 1 1 1 1
long term
follow-up
measure-
ment
1 1 1 0 1 1 0 0 0
supervision 0 0 0 0 0 0 0 0 0
Oxford
Qual-
ity Scale (
Jadad
1996)
2 2 2 1 1 1 1 1 2
2,5 2,5 2,5 2,5 2,5 2,5 3,5 2,5 1,5
(Continued...)
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Delphi list
(Verhagen
1998)
Internal
Validity (
van Tulder
1997)
4,5 4,5 3,5 2,5 2,5 2,5 2,5 2,5 3,5
Total (25) 12 14 12 9 10 10 12 11 12
* -1: in this study selective lost to follow-up was present
Scales Goodwin
2001
Moadel
2007
Oh 2008 Rawl
2002
Ream
2006
Sandgren
2000
Sandgren
2003
Savard
2006
Spiegel
1981
Yates
2005
randomisation1 1 1 1 1 1 1 1 1 1
concealment
of alloca-
tion
0 0 0 1 1 0 0 0 0 1
blinded
outcome
assessor
0 0 0 0 0 0 0 0 0 0
power
calcula-
tion
1 1 0 0 1 0 0 0 0 1
intention
to treat
0 0 0 0 0 0 1 0 0 0
group
sim-
ilarity at
baseline
1 1 0 1 1 1 0 0 0 1
specified
eligibility
criteria
1 1 1 1 1 1 1 1 0 1
drop-out 1 1 1 1 1 1 1 1 0 1
(Continued...)
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(...Continue)
selective
lost to fol-
low-up
1
-1*
0 0 0 0 1 0 0 0
co-inter-
vention
avoided
1 1 1 1 1 1 -1 1 1 1
compliance 1 1 0 0 0 0 1 0 0 1
relevant
measures
1 1 1 1 1 1 0 1 1 1
timing as-
sessments
1 1 1 1 1 1 1 1 0 1
equally
treatment
1 1 1 0 1 1 1 1 0 1
contamination0 0 0 0 0 0 1 0 0 0
protocol 1 0 0 1 1 0 1 0 1 1
training 1 1 1 1 0 1 1 0 1 1
integrity
check
1 0 0 1 0 0 1 1 0 0
adverse
effects
0 0 0 0 0 0 0 0 0 0
sample
size
1 1 1 0 1 1 0 1 1 1
missing
values
0 0 0 0 0 0 0 0 1 0
standard
deviation
1 1 0 0 1 0 0 1 0 1
desc. of
index &
con-
1 1 1 1 1 1 1 1 1 1
(Continued...)
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trol inter-
vention
long term
follow-
up mea-
surement
0 0 0 1 0 1 1 1 0 1
supervision 0 0 0 0 0 1 1 0 1 0
Oxford
Qual-
ity Scale (
Jadad
1996)
2 2 2 3 3 2 2 2 1 3
Delphi
list (
Verhagen
1998)
3,5 3,5 1,5 3 4 2,5 3,5 1,5 0,5 4
Internal
Validity (
van
Tulder
1997)
4,5 4,5 3,5 4 4 3,5 3,5 3,5 2,5 5
Total (25) 17 13 10 13 14 13 15 12 9 17
* -1: in this study selective lost to follow-up was present
The majority of the studies had a moderate methodological qual-
ity, varying between ten and 17. In three studies the quality was
graded a nine, being regarded as poor (Berglund 2007; Faithfull
2001; Spiegel 1981). The methodological quality of the study of
Barsevick 2004 was rated as 18, being good.
One of the items of the Quality Rating Scale was concealment of
allocation and the evaluation is described in the ’Characteristics of
included studies’ table. Eight studies suggested that concealed allo-
cation was used (Godino 2006; Goodwin 2001; Savard 2006) and
in five studies the allocation was concealed adequately (Faithfull
2001; Rawl 2002; Ream 2006; Yates 2005), with one study chang-
ing the procedure during recruitment. In the remaining studies it
was not described which procedure was used to conceal allocation.
Barsevick 2004 was the only study in which an intention-to-treat
analysis was used. Two other studies described that intention-to-
treat analysis was used, however, this remained unclear from the
described analysis and results (Berglund 2007; Goodwin 2001).
In most studies the analysis was performed with participants who
completed all assessments.
Three studies explicitly described that actions were taken to pre-
vent contamination. In the study of Sandgren 2003 nurses gave
both interventions, but the authors attempted to avoid contami-
nation by informing the nurses about the risks of contamination.
In two other studies it was explicitly mentioned that the persons
administering the intervention were different from the persons in
contact with participants in the control condition (Ream 2006;
Yates 2005). In the study that evaluated medical qigong, patients
in the control group were asked to refrain from joining an outside
qigong class (Oh 2008).
An important aspect when evaluating the effectiveness of psy-
chosocial interventions is the adherence of patients, however, in
only 12 studies this was described. In eight studies the atten-
dance of participants joining the sessions was described (Armes
2007; Brown 2006; Classen 2001; de Moor 2002; de Wit 1997;
Goodwin 2001; Moadel 2007; Yates 2005) and in four studies
adherence was assessed in other ways. Two studies measured if
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participants used the behaviours learned during the intervention
(Barsevick 2004; Yates 2005). Two studies asked participants if
they read the provided brochures (de Wit 1997), or practiced at
home (Cohen 2007).
Risk of bias in included studies
The possibility of bias could be found in the characteristics of the
sample. The exclusion criteria varied a lot between the included
studies, for example some studies excluded patients with other co-
morbidities, while some studies did not describe additional exclu-
sion criteria. The methodological quality might also cause a bias,
however, this is described in the discussion in more detail.
Effects of interventions
See: Summary of findings for the main comparison Effective
studies
Seven of the included studies reported a significant effect of the
interventions on fatigue at a 0.05 level. The seven studies and their
results are briefly described in the Summary of findings for the
main comparison: Effective studies. The effect sizes varied between
0.17 (Barsevick 2004) and 1.07 (Cohen 2007). The smallest effect
size was found in the study of Barsevick 2004, but this could be
due to the use of intention-to-treat analysis not applied in other
studies. In two studies it was not possible to obtain all relevant
data to calculate effect sizes (Forester 1985; Spiegel 1981).
Of the seven studies which found a significant effect of the inter-
ventions on fatigue, three found significant time-by-group inter-
action effects at follow-up (Armes 2007; Barsevick 2004; Cohen
2007) on at least one instrument that measured fatigue. In the
studies of Armes 2007 and Barsevick 2004 the follow-up period
was short, up to one month. The follow-up period in the study of
Cohen2007 was longer, lasting fourmonths. In the study ofArmes
2007 participants weremeasured additionally at nine months after
recruitment. Of these seven studies two studies found a significant
effect immediately post-intervention, but these results were not
maintained at follow-up (Forester 1985; Yates 2005). In the study
of Spiegel 1981 significant results were found post-intervention,
but no follow-up assessment was described. The study of Ream
2006 found a significant effect on fatigue comparing the post-
intervention scores with a t-test without controlling for baseline
differences. No follow-up measurement was carried out. The use
of a t-test was justified in this study as baseline fatigue scores of
the control and the intervention group were not significantly dif-
ferent. These seven studies (Armes 2007; Barsevick 2004; Cohen
2007; Forester 1985; Ream 2006; Spiegel 1981; Yates 2005) are
further referred to as the ’effective’ studies.
The remaining 20 included studies were regarded as not effec-
tive. In 17 studies no significant effects of the intervention on fa-
tigue were found, although in four of these 17 studies the authors
concluded that the results were in the expected direction (Given
2002; Goodwin 2001; Oh 2008) or significant on a 0.1 level (
Cunningham 1989). Three of the 20 studies found a significant
effect of the intervention when measured with a t-test, immedi-
ately post-intervention (Decker 1992; Gaston-Johansson 2000) or
at follow-up (Fawzy 1995). In the first study, Gaston-Johansson
2000 reported that the difference between the intervention group
and control group disappeared after controlling for demographic
variables and fatigue at baseline. In the second study of Decker
1992 a statistically significant difference in the pre- versus post-test
scores was found, where control patients became more fatigued.
However, no significant results on treatment by repeatedmeasures
interaction were found on fatigue. In addition, when looking at
the results fatigue scores were higher in the experimental group
compared to the control group, at baseline and post-intervention.
In the third study, Fawzy 1995 found significant results on fatigue
on the within-group analysis and the between-group analysis, but
reported no significant result of the analysis of covariance on fa-
tigue. Thus, using a t-test to evaluate the intervention was not
justified in the last three studies and therefore we concluded that
in 20 studies the intervention was not effective for fatigue.
Comparing effective and non-effective interventions
for fatigue
The quality of the seven effective studies did not differ from the
non-effective studies (P = 0.231). The mean quality score of the
effective studies was 14.0 (s.d. 3.6) compared to 12.2 (s.d. 2.0)
of the non-effective studies. No difference was found in the mean
number of participants (P = 0.598). The mean number of partic-
ipants of the effective studies was 138 (s.d. 115) compared to 118
(s.d. 78) of the non-effective studies.
The psychosocial interventions could be distinguished into inter-
ventions specific for fatigue and interventions not specific for fa-
tigue. The effectiveness of interventions specific for fatigue was
significantly higher at 80% (four out of five) compared to inter-
ventions not specific for fatigue at 14% (three out of 22) (P < 0.01).
Two studies were specific interventions for pain (de Wit 1997),
and depression (Savard 2006), but were not effective for fatigue.
The other interventions not specific for fatigue had a more gen-
eral approach and focused on distress, mood states, quality of life,
or symptoms or side effects in general. Of these 20 studies, three
studies were effective in reducing fatigue (Cohen 2007; Forester
1985; Spiegel 1981).
The five specific interventions for fatigue were short interventions,
consisting of three individual sessions with a duration varying be-
tween ten and 60 minutes. These interventions were to a large ex-
tent based on the same elements. In all interventions participants
were; 1) educated about fatigue; 2) taught in self-care or coping
techniques; 3) taught activity management, learning to balance
between activities and rest. In addition to these elements Ream
2006 emphasised emotional support. In these five studies (oncol-
ogy) nurses administered the interventions and were trained. All
studies included participants with various malignancies and stages
of cancer. In the study described by Armes 2007, the first author
was also the nurse administering the intervention. The study of
Godino 2006 was the only intervention specific for fatigue, that
26Psychosocial interventions for reducing fatigue during cancer treatment in adults (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
was not effective. The most obvious difference between this study
and the effective studies is the smaller number of participants.
Godino 2006 randomised 40 participants, while the sample size of
the effective studies was between 60 and nearly 400 participants.
The three effective studies not specific for fatigue were longer
interventions compared to the interventions specific for fatigue.
The study of Cohen 2007 consisted of nine weekly sessions of 90
minutes. The study of Forester 1985 consisted of ten weekly 30
minute sessions. The intervention in the study of Spiegel 1981
lasted at least a year, in which participants met weekly for 90
minutes. The duration of these three interventions fall within the
range of all other interventions that were not specific for fatigue,
varying between four weeks and a year. The content of these three
interventions varied among each other. The intervention groups
in the study of Spiegel 1981 was primarily supportive and aimed
to benefit patients psychologically. The intervention of Forester
1985 was individual unstructured supportive psychotherapy de-
signed to reduce patients emotional distress and physical symp-
toms, regarding treatment. Cohen 2007 studied the effects of two
group interventions on psychological distress and physical symp-
toms. The first was a cognitive behaviour group intervention and
the second consisted of relaxation and guided imagery. Only the
relaxation and guided imagery intervention appeared to be effec-
tive on fatigue. In the studies of Cohen 2007 and Forester 1985
the first authors were also the only care provider giving the inter-
vention. The effectiveness of the three studies probably couldn’t be
explained by a larger sample size or by a better quality. The quality
scores of the studies by Cohen 2007, Forester 1985, and Spiegel
1981 ranged between nine and 13, while the quality score of the
non-effective studies not specific for fatigue ranged from nine to
17. Thus the quality scores were within the range of the effective
studies not specific for fatigue, and even a bit lower. The number
of participants of the three effective studies ranged between 86 and
114, and was within the range of 30 to 313 of the non-effective
studies not specific for fatigue.
D I S C U S S I O N
The aim of this review was to provide an overview of psychosocial
interventions for fatigue during cancer treatment, and to evaluate
the effectiveness of these interventions. In our search 27 psychoso-
cial interventions were found, in which the effect on fatigue was
tested in a RCT. The sample size of the 27 included studies varied
between 30 and 396, with a total of 3324 participants. The quality
was generally evaluated as moderate.
In general, there is limited evidence that psychosocial interven-
tions during treatment are effective in reducing fatigue in cancer
patients. In only seven studies were the psychosocial interventions
effective in reducing fatigue. In only three studies was the effect
of the intervention on fatigue maintained during the follow-up
period (Armes 2007; Barsevick 2004; Cohen 2007). The quality
and the mean number of participants of the effective studies did
not differ from the non-effective studies. The effect sizes of the
effective studies were generally medium (Field 2005). In the stud-
ies with a large effect size, the intervention was provided by only
one care provider, also being the first author (Armes 2007; Cohen
2007).
Overall the 27 studies were very heterogeneous on most aspects of
the studies, on patient and treatment characteristics, types of inter-
ventions, and outcome measures. This made it difficult to estab-
lish if certain types of intervention or elements could be essential
for reducing fatigue. Attempts were made to draw additional con-
clusions about certain types of interventions or subgroups of pa-
tients. For example a lot of studies were carried out with only breast
cancer patients, but these studies were also too heterogeneous to
draw additional conclusions about interventions for this specific
group. Psychosocial interventions for patients with prostate cancer
or other common types of cancer, are less often tested in RCTs, as
also previously established (Jacobsen 2007). However, it was pos-
sible to distinguish interventions that were specifically designed to
treat fatigue during cancer treatment, and interventions not spe-
cific for fatigue.
This review showed that the effectiveness of interventions specific
for fatigue was significantly higher than interventions not spe-
cific for fatigue. To conclude, at present psychosocial interventions
specifically for fatigue is the more promising type of intervention
for reducing fatigue during cancer treatment. However, there is
currently no solid evidence for the effectiveness of interventions
not specific for fatigue.
Of the five interventions specific for fatigue, four were effective in
reducing fatigue during cancer treatment (Armes 2007; Barsevick
2004; Ream 2006; Yates 2005). In two studies the effects were
maintained in the follow-up period that lasted up to a month
(Armes 2007; Barsevick 2004). One study was not effective (
Godino 2006), but the small sample size might be an explanation
why no significant result was found.
It seems promising that four out of five interventions specifically
designed for fatigue were effective, but the stability of the evidence
is questionable for three reasons. First, in two studies there was
only an immediate effect on fatigue after the intervention, but
the effect disappeared at follow-up (Yates 2005), or no follow-
up assessment was performed (Ream 2006). Second, when more
than one instrument was used to assess fatigue, the effects were
not visible on all instruments. Third, in the study of Armes 2007
the intervention was provided by only one care giver, also being
the first author.
Looking at the characteristics of the five studies that evaluated in-
terventions specifically designed to treat fatigue, revealed two ob-
vious features. Firstly, these studies included patients with various
malignancies and stages of cancer. Secondly, these interventions
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were brief, consisting of three sessions lasting up to 60 minutes
each, and containing to a large extent the same elements. In all in-
terventions participants were; 1) educated about fatigue; 2) taught
in self-care or coping techniques; 3) taught about activity manage-
ment, learning to balance between activities and rest. Based on this
limited number of five studies it could not be established which
format or elements of an intervention were essential for reducing
fatigue. For example, it could not be established if sessions should
be based on face-to-face contact, or if telephone sessions might be
an alternative.
Three out of 22 psychosocial interventions not specially designed
to manage fatigue were effective in reducing fatigue during can-
cer treatment (Cohen 2007; Forester 1985; Spiegel 1981). In one
study the effect on fatigue was maintained during the four month
follow-up period. These three interventions had amore general ap-
proach aimed at psychological distress, mood and physical symp-
toms. There is no obvious reason why these three interventions
were effective, while 19 other studies were not. No explanation
could be found in the sample size, the quality of the studies or
characteristics of the interventions.
There are several reasons that support the conclusion that inter-
ventions with a general approach are rarely effective. First, in the
studies of Cohen 2007 and Forester 1985 the first author was also
the care provider administering the intervention. Second, in only
one study the effect was maintained at follow-up. In addition, one
of these three studies was an early study of Spiegel 1981 and was
replicated in later studies (Classen 2001; Goodwin 2001). How-
ever, the effect on fatigue demonstrated by Spiegel 1981, was not
confirmed in the later two studies.
Interventions that did not focus on fatigue, for example interven-
tions that aimed to reduce depression or pain, showed that fatigue
did not decrease with depression or pain, and therefore we can
conclude that these interventions are not effective for reducing
fatigue.
Limitation of the studies
During the evaluation of the included studies several shortcom-
ings were noticed. In most studies it was difficult to get a clear
picture of the complete cancer treatment participants received,
such as types of treatments and total duration. As a result it also
remained unclear when during cancer treatment the assessments
and the sessions took place. Often it was uncertain if participants
continued with cancer treatment after the intervention.
The evaluation of the quality of the included studies revealed ad-
ditional limitations. In the majority of the studies it was not de-
scribed if a procedure was used to conceal allocation, not even in
the most recent publications. In addition, only one study applied
an intention-to-treat analysis. Recommendations for improving
the quality of RCTs are provided in the CONSORT guidelines (
Boutron 2008).
Several methodological elements of the psychosocial intervention
studies could be improved. For example, avoiding the risk of con-
tamination, and testing the adherence of participants. Training the
care providers, supervising them, and applying an integrity check
would help improve an intervention study.
In some studies the intervention was provided by only one care
provider also being the author, but there might be a conflict of
interest in performing the intervention at the one hand, and pub-
lishing the results at the other. The care provider might work hard
to get positive outcomes, resulting in a large effect size. Despite
the good intentions of realising a good intervention, with only
one practising care provider it could be difficult to transfer the
intervention to others, and to replicate the study. Thus it is rec-
ommended that the intervention should be given to participants
by more than one person.
Limitation of the review
A limitation of this review is that RCTs were excluded when it was
unclear if cancer patients were receiving treatment at the time of
the intervention. To clarify this issue we contacted the experts and
researchers who performed the studies. In addition the possibility
remains that trials with negative results might not have been pub-
lished at all, and therefore are missed during our search. Although
we are unaware that relevant studies were missed, the possibility
that a relevant study exists cannot be ruled out.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
When cancer patients experience fatigue during cancer treatment
there are several options to treat fatigue. In clinical practice an
intervention with a general approach is usually chosen when in-
tervening for fatigue, although at present there is no solid evi-
dence for the effectiveness of psychosocial interventions not spe-
cific for fatigue. This review showed that interventions with a gen-
eral approach were rarely effective in reducing fatigue, and these
interventions focused on psychological distress, mood and physi-
cal symptoms. When other types of psychosocial intervention are
offered to cancer patients, for example with the aim of reducing
depression or pain, it is not likely that symptoms of fatigue auto-
matically decrease with depression or pain.
The effectiveness of psychosocial interventions specifically de-
signed to treat fatigue was significantly higher than interventions
not specific for fatigue, and is currently the more promising type
of intervention for reducing fatigue during cancer treatment. The
interventions specific for fatigue contained, to a large extent, the
same elements. In all interventions patients were: 1) educated
about fatigue; 2) taught in self-care or coping techniques; 3) taught
activity management, learning to balance between activities and
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rest. However, currently with only a limited number of studies it
could not be established which format or elements are essential to
reduce fatigue during cancer treatment.
It is important to note that psychosocial interventions during ac-
tive cancer treatment were the focus of this review. Our results are
therefore not applicable to cancer patients who have completed
their cancer treatment.
Implications for research
This review showed that there is limited support for psychosocial
interventions for fatigue during cancer treatment. At present the
effectiveness of psychosocial interventions specifically designed to
treat fatigue is high, but there is no solid evidence for the effec-
tiveness of psychosocial interventions not specific for fatigue.
As the RCTs were very heterogeneous in nature, and the num-
ber of psychosocial interventions specific for fatigue were limited,
there are still some questions that need to be answered. First, it
is important to know why some psychosocial interventions work,
and therefore interventions should preferably be based on a the-
ory or model. To find essential components that are necessary to
reduce fatigue it is advisable to assess if factors that are expected to
reduce fatigue also change during the intervention. In addition,
the optimal duration of the intervention needs to be established,
and the best method to provide the intervention. For example, it
is unclear if telephone or face-to-face sessions are equally effective.
Also there are no RCTs that evaluated the effectiveness of group
interventions specific for fatigue.
As the included studies were very heterogeneous it was not possible
to identify high risk groups. Thus, the question remains whether
patients with specific malignancies, or patients receiving specific
types of treatments are at risk of becomingmore fatigued, although
some studies point in that direction (Jereczek-Fossa 2002). Some
studies found that the prevalence of fatigue depended on the diag-
nosis. For example, patients with prostate carcinoma reported the
least severe fatigue during radiotherapy and patients with lung,
alimentary, and head and neck carcinoma reported the most se-
vere fatigue (Hickok 2005a). Levels of fatigue also depended on
diagnosis in patients receiving chemotherapy. In a group of can-
cer patients receiving cytotoxic treatment, lung and breast cancer
patients experienced the highest degree of fatigue (Hartvig 2006).
There are also indications that the prevalence of fatigue depends
on the type of treatment cancer patients receive. For example,
breast cancer patients who had amastectomy operation were more
fatigued than women who underwent a lumpectomy. Receiving
radiotherapy supplementary to chemotherapy led to an increase
in fatigue in women with breast cancer (de Jong 2004).
In addition the course of fatigue appears to depend on the type
of treatment cancer patients receive. For example, the course of
fatigue in patients receiving chemotherapy seems to be different
from the course of fatigue in patients receiving radiotherapy. Af-
ter the start of chemotherapy the prevalence of fatigue increases,
remaining stable during chemotherapy treatment (de Jong 2004;
Jacobsen 1999). During radiotherapy the occurrence of fatigue
increases with the number of weeks patients are treated with ra-
diotherapy (Hickok 2005; Hickok 2005a).
If high risk groups can be identified it is important to know if
these groups need adapted psychosocial interventions. In current
guidelines for CRF, interventions for patients on active treatment
are distinguished from interventions for patients at the end of life (
NCCN 2008) although, the effectiveness of interventions specific
for fatigue in this sample still needs to be demonstrated.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Armes 2007
Methods RCT. Originally starting with minimization on basis of age, sex, site, and stage of cancer, and HADS
scores. After 10 patients were allocated, simple random permuted block randomization was implemented.
Sixty participants were randomized, 30 to both groups, the final sample size was 55. Of the experimental
group (EG) 28 completed baseline questionnaires (T0 = cycle 3 of CT), 21 participants completed T1
assessment (end of cytotoxic treatment), 22 participants completed T2 assessment (4 weeks after the end
of cytotoxic treatment), and 17 participants completed T3 assessment (9 months after recruitment). Of
the control group (CG) 27 participants completed T0, 16 completed T1, 22 completed T2, 19 completed
T3. Non response rate varied across assessment from 16 to 5. At T3 14 participants died and 5 were non-
responders (EG 7 died, 4 non response; CG 7 died, 1 non response).
Participants Patients who were attending for chemotherapy treatment were screened for eligibility at 2 cancer centres in
South London. Patients were excluded who 1) were aged < 18 years; 2) did not have histologically proven
cancer or were not aware of their cancer diagnosis; 3) were receiving the last half of the planned course of
cytotoxic treatment; 4) were unable to speak and understand English; 5) did not report significant fatigue;
6) had a poor Eastern Cooperative Oncology Group performance status (>3); 7) had a previous history
of psychotic disorder; 8) had evidence of cognitive impairment or central nervous system metastases; 9)
were receiving psychotherapy or CBT; 10) were receiving cytokine treatment; or 11) had an uncontrolled
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infection at the time of recruitment. The mean age of the 55 participants was 59 years. A majority were
women (n=33) and were white British (n=46). Of these, 27 had a diagnosis of colorectal cancer, 44 had
stage III or IV, and 42 had at least 1 metastasis.
Interventions One trained research fellow (nurse) (first author) provided the intervention, consisting of 3 individual, face-
to-face, 60 minute sessions at 3 to 4 weekly intervals (coinciding with chemotherapy). The components of
the intervention were education of CRF, written information on CRF, discussing effectiveness of coping
strategies; goal setting, activity scheduling, graded task management, self monitoring and modification;
distraction, cognitive restructuring, praise and encouragement. The control group received standard care.
Outcomes Three primary outcomes were measured. Fatigue was assessed using a VAS of global fatigue, physical
functioning (sub-scale of EORTC-QLQ-C30), fatigue-related distress was measured with a Fatigue
Outcome Measure designed specifically for the study. Secondary outcomes were MFI, HADS, and the
EORTC-QLQ-C30.
Notes The duration of the cytostatic treatment is not described.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Not concealed at the start of the study (see methods)
Barsevick 2004
Methods RCT. Participants were stratified by job status (working vs. Nonworking), type of treatment (CTX vs. RT vs.
concurrent therapy), and diagnosis (breast vs. non-breast cancer). Questionnaires were administered at three points.
Baseline assessment occurred before the start of cancer treatment. For participants receiving CTX or concurrent
therapies assessment occurred 48 hours after the second and third CTX. For participants receiving RT assessment
occurred during the last week of treatment and one month after completion of treatment. 396 participants were
included in the study.
Participants Individuals were eligible if they were currently beginning treatment intended for cure of local control, for breast,
lung, colorectal, advanced prostate, gynaecologic, or testicular cancer or lymphoma and if they planned to receive > 3
cycles of high-dose chemotherapy (CTX), 6 weeks of radiotherapy (RT) or current RT and CTX. Other treatment
other than surgery had to be completed one month previously. Exclusion criteria were if the treatment plan included
stem cell transplantation, interleukins, interferons, or tumour necrosis factor, patients with chronic fatigue syndrome,
patients who enrolled on to other studies involving psycho-educational interventions, patients with a psychiatric
disorder, and patients receiving treatment for anaemia or depression. The mean age of the 396 participants was 56.3
years, the majority were female (85%), Caucasian (91%) and college educated (65%). The study was conducted at a
university health science centre and a comprehensive cancer centre.
Interventions Participants allocated to the energy conservation and activity management (ECAM) condition received three
telephone sessions from a trained oncology nurse. Participants were given information on cancer-related fatigue and
learned energy conservation skills. An energy conservation plan was created (coping stage), evaluated and revised
(appraisal stage). The control group received three telephone sessions with information on nutrition, informing and
discussing maintenance of a healthy diet, use of vitamins and minerals. Planned duration for both conditions of the
first two sessions was 30 minutes and the third session 15 minutes. For participants receiving CTX or concurrent
therapy the intervention was administered during the first 3 weeks of treatment. For participants receiving RT the
intervention occurred during week 3 to 5 of treatment.
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Outcomes Fatigue was measured with three scales (POMS-sf, SCFS and GFS). An other outcome was functional performance
Notes How many patients were randomised to the two conditions and how many were lost to follow up is not described. In
addition a description what was done with missing values is lacking.
Berglund 2007
Methods RCT. After stratification on stage of disease, curative treatment and age, 211 participants were randomised to Physical
training (Phys) (n=53), Information (Info) (n=55), information plus physical training (PhysInfo) (n=52) or a control
group (C) (n=51). Questionnaires were completed by 194 participants at baseline, 166 participants at 6 months
follow-up, and 158 participants at 12 months follow-up. Some participants (n=23) dropped-out after randomisation,
others in a later stage for the following reasons; dissatisfied with group assignment, could not arrange transportation.
In addition some questionnaires were not returned, at 6 months follow-up or at 12 months follow-up.
Participants Within six months after diagnosis prostate cancer were included at the university hospital in Uppsala, Sweden.
Participants were excluded if they had another cancer diagnosis, participated in other studies, were patients in
other care programmes, had severe hearing or vision impairment, were not Swedish speaking, or were physically or
mentally disabled. Overall 20% of the participants had metastasis, the most frequent curative treatment was radical
prostatectomy (24%), and 36% did not had active treatment (watchful waiting). The average age was 69 years, 80%
was married and 24% had a university degree.
Interventions Each intervention program included 7 weekly sessions, with group sizes varying from 3 to 10 participants. Phys:
A physiotherapist led 60-minute physical training session followed by a 15 minute coffee break. The programme
included light physical training with movement and fitness training, relaxation and breathing exercises. A booster
session was held 2 months after the conclusion of the training exercises. Info: A nurse led 60 minute information
sessions followed by a 15 minute coffee break. Emphasis was laid on giving the information about prostate cancer,
its treatment (lecture given by an urologist) and potential side effects and how to deal with side effects. PhysInfo:
combination of Phys and Info programs. Participants were given physical training and then information in the same
session, consisting of seven 135-minute sessions. The control group received standard care, i.e. the information and
care that was available at that time.
Outcomes The HADS and EORTC-QLQ-C30 were used. Fatigue was assessed with the fatigue sub-scale of the EORTC QLQ-
C30.
Notes Unclear how many patients completed questionnaires at 12 months follow-up as numbers in the figure are different
from the tables.
Brown 2006
Methods RCT: stratification for tumour type, age, gender, and ECOG score. Of the 115, 57 were randomised to the
experimental condition 58 to the control condition. Before assessment 3 participants cancelled due to illness. 55
participants in the experimental condition completed baseline assessment, 57 in the control condition. Of the
experimental condition 46 completed the assessment at week 4, 6 were found ineligible due to lack of session
attendance. Of the control condition 54 completed the assessment at week 4.
Participants Eligible participants were adult advanced cancer patients scheduled to undergo radiation therapy, recruited at the
division of radiation oncology mayo clinic Rochester. Participants had to be diagnosed with cancer in the past 12
months, have an expected survival of at least 6 months, but a 5-year survival probability of no more than 50%, and
37Psychosocial interventions for reducing fatigue during cancer treatment in adults (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Brown 2006 (Continued )
recommended radiotherapy for at least two weeks. Exclusion criteria was a MMSE-score less than 20, an ECOG
performance score of 3 or more, active alcohol or substance dependence, active thought disorder, suicidal plans, or
participation in a psychosocial trial. The mean age of the 115 participants was 59.6 and 66 of the participants were
male.
Interventions In the structured multidisciplinary intervention participants attended eight 90-minute sessions over the first 4 weeks
after enrolment. A psychiatrist or a psychologist led each session; depending on the theme (mental, emotional,
physical, social, spatial), an advanced practice nurse, a chaplain, or a social worker co-facilitated each session. Sessions
began with 20 minutes of exercise conducted by a physical therapist followed by educational information, cognitive-
behavioral strategies, discussion, and support. Sessions concluded with a 10 to 20 minute guided relaxation exercise.
Participants received a manual and specific education brochures. The control group received standard medical care.
Outcomes Fatigue was assessed as a secondary outcome, measured with LASA, POMS, and SDS at baseline and at week 4, 8, 27
and STAI at baseline. In addition raw scores were transformed to a 0 to 100 point scale as fatigue QOL.
Notes Not described how many patients completed the assessment at week 8 and 27.
Classen 2001
Methods On completion of baseline testing, participants were randomised to intervention or control conditions using the
adaptive randomisation biased coin-design method. The adaptive randomisation method used the following variables:
1 dominant site of metastasis at study entry, 2 estrogen receptor status, 3 disease-free interval, metastasis or recurrence,
4 age at study entry, 5 systemic treatment received since metastasis, 6 institution. 102 women were included in
the data analysis, with patients who completed a pre-randomisation baseline measure and at least 1 post baseline
assessment. 23 of the 125 women randomised into the study did not complete any post-baseline assessments: 15 of
these 23 participants were too ill to complete questionnaires (4 treatment and 11 control participants), 2 were too
busy (both control participants), 4 withdrew from the study because they were not assigned to a support group, 1
withdrew because she did not like the support group, and 1 assigned to the treatment condition withdrew for no
stated reason. 64 women were randomised to the intervention arm of the study and 61 to the control arm. Post-
baseline assessments were conducted every 4 months during the first year and every 6 months thereafter.
Participants Women with confirmed metastatic or locally recurrent breast cancer were recruited through the Oncology Day Care
Center at Stanford University Medical Center. Patients were eligible if they had a Karnofsky score of at least 70%,
were proficient enough in English to be able to respond to questionnaires and participate in a support group. Women
were not included with positive supraclavicular lymph nodes as the only metastatic lesion at the time of initial
diagnosis; active cancers within the past 10 years other than breast cancer, basal cell or squamous cell carcinomas of
the skin, in situ cancer of the cervix, or melanoma with a Breslow depth less than 0.76 mm; or concurrent medical
conditions likely to affect short-term survival. At study entry 41% of the control group received chemotherapy and
84% hormone therapy. Of the treatment group 43% received chemotherapy and 81% received hormone therapy. The
mean age of the control group was 54, the mean education was 19 years, and 80% was white. The mean age of the
treatment group was 53, the mean education was 16 years, and 91% was white.
Interventions Participants in the treatment group, the size ranging from 3 to 15, met weekly for 90-minute sessions. The intended
duration of treatment was 1 year. The therapy sessions were facilitated by 2 therapists. Therapists included a
psychiatrist, psychologists, and social workers. The supportive-expressive therapy model involved the creation of
a supportive environment in which participants were encouraged to confront their problems, strengthen their
relationships, and find enhanced meaning in their lives. Psycho education was provided in a similar fashion, with group
members sharing knowledge they gathered about the illness and related issues. The intervention was unstructured,
neither coping strategies nor psycho education was taught in a didactic manner. Each session ended with a self-
hypnosis exercise to help participants manage stress and deal with pain. Participants were encouraged to use this
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exercise at home. All participants (also from the control group) were offered self-directed education materials. They
were given a list of materials to select from and to take home on loan. The selection of 30 books, 15 pamphlets, 5
videotapes, and 7 audiotapes covered a wide range of topics related to breast cancer.
Outcomes The Profile of Mood States (POMS) was used to assess mood disturbance, including the sub-scale fatigue. The Impact
of Event Scale (IES) was used to assess trauma symptoms.
Notes Results of the six months follow-up measurements after the intervention are not described.
Cohen 2007
Methods RCT. The number of participants was 38 in the cognitive-behavior (CB) group, 39 in the relaxation and guided
imagery (RGI) group, and 37 in the control group (CG). Participants completed questionnaires at three time point:
pre-intervention, post-intervention, and at the end of a 4-month follow-up after the CB and RGI groups concluded.
Several women did not complete the post-intervention or follow-up questionnaires: 3 from the RGI group, 1 from
the CB group, and 6 from the CG.
Participants Breast cancer patients, stages I and II, who were 2 to 12 months since surgery and receiving treatment (chemotherapy
or radiotherapy) were invited to participate in the outpatient unit of the oncology centre. Inclusion criteria were
fluent spoken Hebrew and absence of a psychiatric illness known to the oncology staff. The mean age of the women
was 55.9 (CB), 51.8 (RGI), and 52.9 (CG). The mean education in years was 13.5 (CB), 13.2 (RGI) and 12.8 (CG).
The majority were married 76.3% (CB), 64.1% (RGI), and 81.1% (CG). The time since diagnosis was 6.9 (CB), 7.2
(RGI), 6.5 (CG) months. A majority received chemotherapy 60.5 (CB), 64.1 (RGI), 56.8 (CG).
Interventions The interventions were conducted by the first author, a senior social worker and expert in psycho-oncology, with
training and experience in CB techniques. Each group of 6 to 8 participants met weekly, for nine 90-minute sessions.
CB: Cognitive components focused on learning to elicit negative thinking patterns and restructure them into
adaptive patterns and stress-reducing thoughts. In addition mental distraction, problem-solving, and decision-making
strategies were taught. Behavioral components focused on activity scheduling, graded task assignment and behavioral
distraction. Practicing at home was emphasized, with homework exercises, and written material was provided. RGI:
Systematic learning of deep RGI, practicing deep breathing and autogenic relaxation. Experience of practice at home
was discussed to give reassurance and work on problems in the relaxation process. Participants also practiced anxiety,
pain, and nausea reduction, and strategies to overcome sleep problems. Participants were provided with RGI audio
cassettes or compact disks for activity at home. Patients in the control group received standard care in the oncology
unit.
Outcomes The Fatigue Symptom Inventory (FSI) was used to measure fatigue. Other instruments used were the Brief Symptom
Inventory, the Perceived Stress Scale, the Mini Sleep Questionnaire, and the Multidimensional Health Locus of
Control.
Notes The two interventions could overlap in the use of a behavioral strategy such as distraction. Group processes, such as
mutual support, exchange of information, and expression of feelings, took place in both groups.
Cunningham 1989
Methods RCT. 60 participants were randomly assigned into one of the two treatment arms: (30 to both groups). They were
stratified by the authors according to age, sex and apparent seriousness of disease. Seven dropped out of the therapy
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(three dying during the program, three being too ill to attend, and one for unknown reasons), leaving 53, 28 in the
psycho educational therapy plus supportive discussion, 25 in supportive discussion only. All assessments were being
administered, by the authors, at the beginning of the first weekly session of each intervention, at the end of the last
weekly session, and for a third time 2 to 3 weeks later.
Participants The participants were consecutive admissions to an ongoing coping skills training program at a large metropolitan
cancer centre. They were referred by a variety of health professionals, or self-referred. The group was heterogeneous in
demographic and disease characteristics, about half having recurrent disease, and half being on some form of medical
treatment (chemotherapy, radiotherapy or hormone treatment) at the time the interventions began. Of the psycho
educations group (n=28), 20 were female, the mean age was 48, 13 had breast cancer, and 16 did not receive treatment
at start of the groups. Of the discussion control group (n=25), 19 were female, the mean age was 49, 12 had breast
cancer, and 12 did not receive treatment at start of the groups.
Interventions Both interventions occupied 6 weekly, 2-hour sessions with groups from 7 to 10 participants and a single leader.
The psycho educational intervention included in addition to supportive discussions, education in coping skills. The
training comprised two sessions of relaxation, two sessions on the use of positive mental imagery and one session
each centred around goal-setting and on general lifestyle management. Where coping techniques were taught, they
were practised first in the group after which participants were asked to continue the practice at home with the aid of
a workbook and two audiotapes. These groups were conducted by the first author, at that time a graduate student
in clinical psychology. The control intervention consisted of supportive discussion, ventilation of feelings, general
problem solving and information sharing. The leader was the second author, a senior nurse.
Outcomes The POMS was used, including the sub-scale fatigue. The symptom checklist (SCL-90-R) was also used.
Notes
de Moor 2002
Methods RCT. On the day of the first vaccine treatment, 42 participants completed questionnaires and were then randomly
assigned to an expressive writing (EW) group or a neutral writing (NW) group using minimization. Patient
characteristics used for assignment were: gender, number of metastases, and non-lung metastatic involvement.
Participants completed follow-up assessments on the day of the fourth writing session and 4, 6, 8 and 10 weeks later.
Of the 21 participants in the EW group 2 dropped out prior to the follow-up, and one participant died during the
study. Of the 21 participants in the NW group 3 dropped out and two died during the study.
Participants Patients with newly diagnosed stage IV renal cell carcinoma were recruited from a Phase II trial. Inclusion criteria for
the Phase II trial were that all participants had a life expectancy of > 4 months, a Zubrod performance status of 2, no
serious intercurrent illnesses, and no brain metastases. Prior to enrolment participants could not have received any
chemotherapy, or immunotherapy. Participants underwent a nephrectomy and vaccine treatment. In both groups,
the average age was 56 years, 86% were male, and 76% had two or more metastases. Participants with non-lung
involvement was 76% in the EW group and 71% in the NW group.
Interventions The writing sessions for both groups were conducted at each of the first four weekly clinic visits while the participants
waited to receive their vaccine treatment. Participants were given verbal and written instructions. Participants in the
EW group were instructed to write for 15 minutes about their deepest thoughts and feelings about their cancer. The
instructions remained essentially the same for each assignment. The participants in the NW group were instructed to
write about a different health behaviour at each session, which comprised diet, physical activity, substance use and
sleep.
Outcomes The outcome measures were symptoms of distress (IES), perceived stress (PSS), mood disturbance (POMS), and sleep
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disturbances (PSQI). Fatigue was measured with a sub-scale of the POMS.
Notes The results represented the overall group means averaged across the five follow-up measures, for both groups. In
addition it was not described how many participants the statistical analysis was performed upon.
de Wit 1997
Methods Cancer patients who would receive district nursing at home and patients who would not receive district nursing were
studied separately. Both patient groups were randomly assigned to a control or an intervention group, after stratifying
for three variables: gender, age, and metastatic sites. Summarizing, four study groups were distinguished: 1) a control
group without district nursing (n=103); 2) an intervention group without district nursing (n=106); 3) a control group
with district nursing (n=51); and 4) an intervention group with district nursing (n=53). Patients were approached
to participate after admission to the hospital. All participants were followed up by telephone at 2 (T1), 4 (T2), and
8 weeks postdischarge (T3). (Group (1) T1: N=94, T2: N=86, T3: N=78. Group (2) T1: N=100, T2: N=97, T3:
N=85. Group (3) T1: N=44, T2: N=43, T3: N=41. Group (4) T1: N=39, T2: N=33, T3: N=31).
Participants The study was carried out in the Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands. The following
inclusion and exclusion criteria were used: 1) pain related to cancer, cancer therapy, or illness; 2) pain duration of at
least 1 month; 3) life expectancy of at least 3 months; (4) able to read and speak Dutch; (5) accessible by telephone;
and (6) not residing in a nursing home or retirement home. Participants had various types of primary tumours and
extent of the disease. At baseline 22.4% of the participants did not receive cancer treatment, 62.6% were female,
25.9% had a higher education and the mean age was 55.5 years.
Interventions Three nurses gave the Pain Education Program (PEP). The PEP consists of three components:
1) Enhancing patients’ knowledge about pain and pain treatment. A patient was instructed about a specific pain topic
only when that topic was assessed as applicable to the patient, and only when the patient’s knowledge about pain and
pain treatment was assessed as insufficient. This tailored information was provided on a one-to-one setting lasting
between 30 and 60 minutes. The verbal instruction was accompanied by a pain brochure consisted of two parts: (A) a
section with general information aimed at all cancer pain patients, and (B) a loose-leaf part given to patients when
applicable, including supplementary sheets with information about different cancer pain treatments.
2) Participants were instructed on how to register their Present Pain Intensity twice daily in a pain diary for a period
of 2 months. In addition, participants were instructed to document changes on type of pain and use of (non-
)pharmacological pain treatment.
3) Stimulating patients’ help-seeking behavior. Participants were instructed on how to use simple non-pharmacological
pain management techniques, such as cold, heat, relaxation, and massage, at home when pain relief was insufficient.
They were encouraged to contact health care providers if necessary. Besides the instruction provided in the hospital,
participants were called at home at 3 and 7 days post-discharge by the same nurse to determine whether the instruction
was fully understood, and to offer the opportunity to ask questions. These phone calls took 5 to 15 minutes each.
Outcomes Pain experience was measured with the MCGill Pain Questionnaire Dutch Language Version (MPQ-DLV). Present
and Average Pain Intensity was measured with a numeric rating scale. Pain knowledge was measured with PKQ-DLV.
Quality of life was measured with the EORTC-QLQ. Fatigue was measured with the symptom list of the EORTC-
QLQ.
Notes Drop out rate in the intervention group with district nursing was much higher compared to the other three groups,
thus possible selective drop-out.
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Methods RCT. Baseline assessment took place prior to radiation therapy. The post intervention assessment took place at the
sixth session, for both groups. 34 participants of the relaxation group completed the post-intervention assessment, 29
of the control group.
Participants Eligible participants were recently diagnosed cancer patients scheduled to receive external beam radiation. Patients
with prior cancer were excluded, those who received prior radiation therapy, in-patients, or those with suicidal ideas.
74 were treated with curative intent, 8 with palliative intent. Of the 82 patients randomised 30 were males, the mean
age was 61 years.
Interventions Participants receiving relaxation treatment met individually for six 1-hour sessions with a graduate student supervised
by the first author. In addition to relaxation training, support focused on concerns related to cancer radiation
treatment and its effects on physical and emotional sensations. Participants were instructed to perform relaxation each
day at home and were provided with a relaxation tape and written instructions. The control group completed the
assessment and received standard education and support along with the radiation therapy. All participants received
the usual services during radiation therapy.
Outcomes Fatigue was measured with the POMS sub-scale fatigue.
Notes
Edelman 1999
Methods RCT. For every 20 participants that were recruited a block randomisation procedure took place, with ten to each
condition. Of the 124 participants recruited 32 were classified as dropouts (16 died, 10 due to illness, 3 were found
not have metastatic disease, 3 other reasons. Ninety-two completed baseline questionnaires, 43 in the CBT group
and 49 in the control group (CG). The 3 month assessments was completed by 36 CBT and 37 CG. The 6 month
assessment was completed by 31 CBT and 32 CG.
Participants This study focused on metastatic breast cancer patients recruited from the Royal North Shore Hospital Sydney.
Eligibility criteria included: ability to attend group sessions; no concurrent psychiatric disorder, organic brain disorder
or drug/alcohol dependency; ability to speak and read English; and aged between 30 and 65 years. Of the recruited
participants 47% were between 41 and 50 years old, 63% was married. It was not described whether participants
received treatment during the intervention.
Interventions Therapy recipients attended eight weekly sessions of group CBT, followed by a family night, and three further monthly
sessions. The programme was led by two therapists and incorporated the use of cognitive and behavioural techniques,
encouraging the expression of feelings and building of group support. Participants received a manual, handouts and
homework exercises at every session. In the first few sessions participants were taught basic cognitive skills, including
how to identify and challenge maladaptive thoughts and beliefs. Behavioural techniques were introduced in the
second sessions, with a discussion on deep relaxation/meditation as a tool for managing anxiety. Participants received
a relaxation tape and were encouraged to practise. The no-therapy control group received standard oncological care.
Outcomes The POMS was used to measure mood, including the sub-scale fatigue. The Coopersmith Self-esteem Inventory-
Adult form was also used to measure self-esteem.
Notes
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Methods RCT. 115 men were randomised and stratified to provide a balanced representation of men with prostate
and bladder cancer. Both groups were assessed within the first week of starting RT, week 3, 6, and at 12
weeks following start of RT. There was a decrease in completion of questionnaires over time (88% at week
6). 81% of the EORTC QLQ was returned at week 12.
Participants Men included in the study were those undergoing radical (greater than 60 Gy) radiotherapy for prostate
(83%) or bladder cancer (17%). The mean age of the men was 70 in both groups.
Interventions The nurse-led care (intervention) was organised for within the first week and last week of RT. Appointments
were for 20 minutes and further appointments could be negotiated as required. The nurse explored the
individual’s understanding of their diagnosis, symptoms and the meaning of the illness. The intervention
provided participants with information and practical advice on how to recognise early symptoms, what
to expect from treatment and how to manage existing problems. The nurse also provided men and their
families with leaflets on healthy eating, RT and how to manage urinary symptoms during RT. The control
group received conventional care consisting of routine medical appointments lasting 10 minutes. These
were arranged at the start of RT, continuing weekly for patients with bladder cancer, or 2-weekly for
patients with prostate cancer, throughout the duration of RT, and led with a group of 6 physicians.
Outcomes Data collected were observer-rated toxicity scores (RTOG/EORTC), self-assessment of symptoms (VAS),
quality of life (EORTC QLQ-C30), satisfaction with clinical care (based on Newcastle satisfaction with
nursing scale), costs. Fatigue was measured with a VAS and a sub-scale of EORTC QLQ-C30.
Notes Missing data were removed from analysis. Therefore the number of participants varies from 56 at week 1
to 25 at week 12, in the intervention group (SES)
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes adequate
Fawzy 1995
Methods RCT. Stage I patients were recruited at time of their postoperative checkup and stage II patients when they began
immunotherapy protocols. At recruitment participants were asked to fill in the baseline questionnaires. At baseline (t0)
31 participants were randomised to the intervention group and 32 to the control group. Follow-up Questionnaires
were mailed to all participants, six weeks (t1) and 3 months (t2) after completion of the intervention. At t2 three
participants were lost to follow-up, leaving 28 participants in the intervention group and 32 in the control group.
Participants This study focused on patients with malignant melanoma, stage I or II. Any Breslow depth and Clark levels I-V
were acceptable. Participants had to be at least 18 and no older than 70, able to speak and read English and have no
previous history of cancer or psychiatric treatment. The mean age of the experimental condition (n=29) was 42, all
were white, 15 were males, and 24 had a college degree or higher. The mean age of the control group (n=33) was 46,
30 were white, 19 were males, and 19 had a college degree or higher.
Interventions Participants randomised to the psycho educational nursing intervention received an educational manual and 3 hours
of individualized teaching on two separate occasions from an oncology nurse. The first session was after baseline
testing, the second was made coinciding with the patients’ next clinic visit. The intervention consisted of three specific
nursing goals and strategies. Health education, stress management, including teaching about stress, stress monitoring
and relaxation exercises, and enhancement of coping skills. Participants were called by the nurse prior to the second
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appointment to remind them of the appointment and to do the reading and relaxation exercises. The control group
did not receive the intervention but completed the questionnaires.
Outcomes Affective state was measured with the BSI and POMS, which includes the sub-scale fatigue/inertia. The Dealing with
Illness Inventory was used to asses health seeking and coping behaviours.
Notes The numbers of patients participating is not clear. Different numbers are described at baseline, and the numbers at t1
are not described.
Forester 1985
Methods RCT. 48 participants were randomly selected from the 100 patients to receive psychotherapy, the other 52 participants
served as control subjects. Assessments were made at five points, at baseline (week 0), midpoint in radiotherapy (RT)
(week 3), end of RT (week 6), 4 weeks after RT (week 10), 8 weeks after RT (week 14).
Participants Participants were randomly selected before they received 6 weeks of radiotherapy for cancer. Patients with abdominal
cancer were excluded. The mean age of the participants given psychotherapy was 62.4 years (n=52), 54% were men
and 71% was married; of the control group (n=48) the mean age was 61.5 years, 46% were men and 67% were
married.
Interventions Participants given the intervention were given weekly supportive psychotherapy for 10 weeks (4 weeks beyond
completion of RT). The sessions were provided by the first author and lasted 30 minutes. The content was
unstructured and focused on perceived patients needs, helping them deal with their emotions regarding treatment.
For the majority the sessions were composed of supportive psychotherapy with explanatory, educational, interpretive,
and cathartic components. The control group received only RT.
Outcomes The outcome measure was a SADS interview measuring emotional symptoms, physical symptoms, including a
anorexia, nausea and vomiting, and a fatigue scale.
Notes It seems that of the 100 participants all assessment were available. Nothing is mentioned on missing data or loss to
follow up.
Gaston-Johansson 2000
Methods RCT. The final sample was 110 participants with 52 in the intervention group (IG) and 58 in the control group
(CG). The participants completed the questionnaires at baseline, 2 days before autologous bone marrow/peripheral
blood stem cell transplantation (ABMT), and 7 days after the ABMT provided by the BMT clinical nurse specialist.
Participants Eligibility criteria for the participants required a diagnosis of stage II, III or IV breast cancer; a scheduled ABMT at an
urban National Cancer Institute-designated comprehensive cancer centre; age of 18 years or older; and ability to read
and write English. Most participants were between 41 and 50 years old (50% in the IG and 56% in the CG). Most
participants had a college or graduate degree (65% in the IG and 51% in the CG) and were white (89% in the IG
and 83% in the CG).
Interventions The comprehensive coping strategy program (CCSP) was taught to participants by a clinical social worker at least 2
weeks before hospital admission for treatment with high-dose chemotherapy and ABMT. During the intervention
preparatory information was presented explaining that adequate control of pain can lead to decreased psychological
distress and a decrease in physical symptoms such as fatigue. Several handouts were given explaining theoretical
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considerations and the use of relaxation exercise with guided imagery, and coping self-statements. Cognitive
restructuring information focused on the avoidance of catastrophising distorted thinking. Relaxation with guided
imagery was presented via live model and participants were given an audiotape and recorder with earphones to guide
them through the relaxation exercise. Participants were instructed to use it every day and before stressful events. The
CCSP was reinforced by an ABMT oncology nurse, the principal investigator or the project director, on the day
patients were admitted to hospital, 2 days after completing of chemotherapy, and 7-9 days after ABMT. The control
group did not receive CCSP.
Outcomes The outcome measures were pain (POM), nausea (VAS), fatigue (VAS), psychological distress (anxiety (STAI) and
depression (BDI)).
Notes
Given 2002
Methods RCT. 113 participants were randomised, 53 to the experimental condition (EG), 60 to the control group (CG), and
were interviewed for baseline assessment, within eight weeks of the participants initiating chemotherapy. The second
interview, 10 weeks following baseline was completed by 42 participants of the EG and 48 of the CG. The third
interview, 20 weeks following baseline was completed by 35 participants of the EG and 43 of the CG.
Participants Participants were eligible when they were within 56 days of the first cycle of chemotherapy, after a new cancer
diagnosis, for colon, breast, lung cancer, non-Hodgkin lymphoma or other solid tumours. Participants had to be at
least 40 years of age, and had to report both pain and fatigue at baseline. In addition participants had to be cognitive
intact and able to read English. Patients were excluded when they were not expected to survive the duration of the
study. Four out-patient cancer treatment sites were used for this study. Two sites were affiliated with comprehensive
cancer centres, and two were community cancer treatment clinics. The mean age of the sample was 58 years, 28% was
male, and 73% had some college education. About 70% had advanced cancer (stages III of IV).
Interventions The intervention given by nurses with a certification in oncology, was a 20-week during intervention with 10 sessions
at two weeks interval. Six sessions were in person, lasting one hour, and four were via telephone, lasting 20 minutes.
With the use of a computer assisted protocol, symptoms were assessed, including fatigue. For each problematic
symptom an intervention strategy was created and in later sessions modified, changed or deleted depending on the
result. Intervention strategies were categorized as teaching, counselling and support, coordination and communication.
The control group did not receive the intervention, but did completed the interview assessments.
Outcomes Symptoms, the primary outcomes, were measured with the SES, with fatigue as one of the symptoms. Functioning
was measured with the SF-36 (short-form) as secondary outcome.
Notes
Godino 2006
Methods RCT. Participants were stratified based on diagnosis and treatment with mono-chemo therapy or multi-
chemotherapy schedule. 40 participants were randomised, 23 to the intervention, 17 to the control
condition. A second assessment was available from 16 participants, from the experimental condition only.
The third assessment was available from 13 participants who received the intervention and 7 participants
from the control condition. Part of the participants were lost to follow-up because they declined in health.
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The three assessment were carried out at the same time as the sessions of the intervention.
Participants Eligible participants were diagnosed with gastric or colon cancer, and who were undergoing chemotherapy
at time of the study. Other inclusion criteria were Karnofsky Index >70 and willing to sign the consent
form. Exclusion criteria were previous cancer treatment, including surgery, radiotherapy or chemotherapy;
presence of respiratory; cardiac or hepatic dysfunctions; learning disability and central nervous system
metastasis. The mean age of the experimental group was 58.5 years (30 to 75), of the 23 participants 12
were men and 11 had primary school as education. The mean age of the control group was 62.7 years,
of the 17 participants were 9 men and 8 had primary school as education. The study was carried out in a
comprehensive cancer centre in Barcelona.
Interventions The experimental group received an individualised intervention over three sessions given by an experienced
nurse. The first session during the first cycle of chemotherapy, the second session during the second cycle
of chemotherapy, the third session one month after finishing treatment. The issues discussed during the
sessions included nutrition, stress management, rest and sleep, activity to maintain energy, lifestyle changes
and adjustment. Family members could attend and written information was provided to participants.
Control group received the usual information provided to patients by cancer nurses and data were collected
during the first and the third session.
Outcomes Fatigue was measured with the FACT-F as primary outcome. Satisfaction with the nursing intervention
was assessed with a self-completed questionnaire consisting of 10 items.
Notes The differences in fatigue scores were not significant, but results are not described.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes Not adequate
Goodwin 2001
Methods Randomisation was performed centrally with the use of sealed envelopes containing allocations form
a computer generated table of random numbers, was stratified according to the centre (7 sites) and
the presence or absence of visceral metastases. A 2:1 ratio (intervention/control) was used. Of the 237
women randomly assigned. Two of them were found ineligible - one woman (control group) did not have
metastases, and one woman (intervention group) had a carcinoid tumour. These women were excluded
from the analysis. The analyses included the 218 women who completed baseline questionnaires during
the four months before randomisation (146 in the intervention group and 72 in the control group). After
one year, 102 completed the POMS in the intervention group, and 45 in the control group.
Participants Inclusion criteria: histologic confirmation of breast cancer at the time of diagnosis, presence of metastatic
disease outside of the breast and ipsilateral axilla, consent of the most responsible treating physician.
Exclusion criteria: central nervous system metastases, life expectancy of less than 3 months as assessed
by the treating oncologist; active psychosis, untreated major depression, or severe character disorder;
inability to speak and read English; planned participation in a therapist-led support group for patients
with metastatic breast cancer outside of the study centre; and residence of more than 1 hour from the
study centre. At randomisation 73.9% of the women in the intervention group were currently married,
and the mean age was 49.5. Currently 41.1% received chemotherapy, 43.0% hormone therapy, and 3.2%
radiotherapy. In the control group 69.3% of the women were currently married, and the mean age was
51.5. and 14.3% did not had active treatment. Currently 39.0% received chemotherapy, 46.8% hormone
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therapy, and 6.5% radiotherapy.
Interventions Women in the intervention group participated in a weekly 90-minute therapist-led group of supportive-
expressive therapy. Each group consisted of 8 to 12 women and two leaders. The leaders were psychiatrists,
psychologists, social workers, or nurse clinicians who were experienced in leading group therapy. The
supportive-expressive therapy was intended to foster support among group members and to encourage the
expression of emotions about cancer and its broad ranging effects on their lives. Women were encouraged
to interact with each other and to support each other outside of the group sessions. Participants were
given the opportunity and support to speak about the effects of the illness, its treatment, and changes in
their self-image, roles, and relationships with family members, friends, coworkers, health care providers,
and others. The women also discussed the life-altering nature of the illness and strategies for coping and
communicating. They were asked to attend the group sessions for at least one year. A monthly 90-minute
session was provided for family and friends. Women in the control arm did not participate in a support
group. Every 6 months, all women received educational materials about breast cancer and its treatment,
relaxation, and nutrition.
Outcomes The primary outcome for this trial was survival. Psychosocial function was assessed by self-reported
questionnaires including the POMS fatigue-inertia sub-scale. Pain and suffering was measured with a VAS.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes not adequate
Moadel 2007
Methods RCT: After baseline assessment, participants were randomly assigned to start classes either immediately or in 3 months.
The baseline assessment was conducted in person, the follow-up assessment by telephone on a day when participants
did not attend a yoga class previous to the assessment. 164 women consented to participate. Random assignment was
in a 2:1 ratio to intervention (n=108) or control (n=56) after stratification by treatment (chemotherapy or antiestrogen
therapy). 128 (78%) completed the baseline and follow-up assessment (yoga=84, control=44). In the yoga group 24
participants were study drop-out, 16 were lost to follow-up, 5 refused, and 3 had a change in health status. In the
control group 12 participants were study drop-out, 8 were lost to follow-up, 3 refused, and 1 had a change in health
status.
Participants Eligibility included age ≥ 18 years, new/recurrent (stage I to III) breast cancer diagnosis within previous 5 years,
high performance status (Eastern Cooperative Oncology Group performance status of < 3), ability to speak English
or Spanish, and not actively practicing yoga. Throughout the study 48% of the participants were receiving medical
treatment. Of the sample (n=128) 27 received CT, 30 received antiestrogen therapy and 10 received radiation
treatment at baseline. Participants were 42% African American, 31% Hispanic, and 23% white; mean age was 54,8
years, and 69% of patients were not currently married. Three quarters of the sample earned up to, but no greater than,
a high school degree.
Interventions The yoga intervention consisted of 12 1,5-hour weekly classes. Participants were permitted to attend more than one
class per week. The yoga intervention was developed for use with breast cancer patients by one of the co-authors
(C.S.), an oncologist and certified yoga instructor, in consultation with experts in India and the USA. Based on
Hatha yoga techniques, the intervention incorporated the following three major yoga components: physical stretches
and poses; breathing exercises; and meditation. Participants were asked to practice yoga at home daily and given an
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audiotape/compact disk for guidance. The control group started classed after 3 months.
Outcomes QOL was measured with FACT. The FACIT-fatigue was used to assess limitations in daily activity and energy level.
The FACIT-spiritual was used to assess spiritual and existential well-being. A Distressed Mood Index was developed
using 19 feelings-state descriptive adjectives from the Profile of Mood States.
Notes
Oh 2008
Methods RCT: 30 participants were randomly assigned into the intervention group (n=15), and the control group
(n=15). The randomization was stratified by treatment at baseline (currently ongoing chemotherapy or
completed the cancer treatment). Randomization was done by a computer program. 18 participants
completed the study, 8 from the intervention group (MQ) and 10 from the control group. Reasons were
the time schedule was not suitable (n=3), family holiday (n=2) and sickness (n=2). Five participants of the
control group did not respond to the questionnaires and were not reachable to provide reasons. At the end
of the program all participants were assessed.
Participants Inclusion criteria were: a confirmed diagnosis of cancer at any stage, 18 years of age or older, an Eastern
Cooperative Oncology Group (ECOG) performance status of 0-3, an expected survival length of more
than 12 months, and ability to complete all questionnaires. Exclusion criteria were: diagnosis of other
major medical or psychiatric disorders, a history of epilepsy, brain metastasis, delirium or dementia,
medical contraindication for exercise and already practicing Qigong. Participants ranged in age from 35 to
75 years old (mean 54, s.d. 9). Most were females (75%), living with a partner (67%), and of Caucasian
ethnicity (84%). Of the participants 53% were on active treatment.
Interventions The intervention was a Medical Qigong (MQ) group therapy program, modified to specifically target the
needs of cancer patients to control emotion and stress as well as improve physical function. The MQ group
was lead by an experienced MQ instructor. Participants attended class once or twice a week for eight weeks
that lasted totally 90 minutes, and it was recommended that they carried out practice at home every day for
at least an hour. Each session consisted of 15 minutes of general discussion, including the philosophy and
principle behind the intervention, patients’ feelings and experiences of treatment; 30 minutes of stretching
and body movements; 15 minutes movement in seated posture; and 30 minutes of breathing exercise,
meditation and visualization. The control group received usual care and were asked to refrain from joining
an outside Qigong class.
Outcomes Participants completed the EORTC QLQ-C30, including the symptom scales (fatigue, pain, and nausea
and vomiting).
Notes Change scores of side effects were only tested within groups. Not between groups. Change scores for the
MQ group and the control group were not significant for fatigue.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Unclear Randomization was done by a computer program.
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Methods RCT. 120 participants were randomised, 31 did not continue in the study (21 in the intervention group
(IG), 10 in the standard care group (CG)). 109 patients provided data for analysis, at baseline, 94 (55 IG,
54 CG), 94 at time 2, which was midway through the intervention (9 weeks), and 77 at time 3 which was
one month post intervention (24 weeks). Group assignment was generated via computer and stratified
according to, site of recruitment, site of the patients’ cancer, and care givers’ employment status.
Participants Patients newly diagnosed with breast, colorectal, or lung cancer who were undergoing chemotherapy were
approached within 56 days of initiating chemotherapy, in a tertiary-cancer centre or a community-based
cancer centre. Participants were eligible if they were 18 or older and spoke English. Of the 109 participants
91% were Caucasian, 77% were female. 51% had breast cancer, 23% colorectal cancer, and 27% lung
cancer. The average age was 55.7 years. The sample was distributed evenly between early (stage I or II) and
late (stage III or IV) cancers. Education levels were fairly heterogeneous.
Interventions The intervention was a computer-based nursing intervention and occurred over 18 weeks consisting of
nine visits (five in person (1 hour) and four via telephone (20 minutes) with a masters’-prepared oncology
nurse specialist. It was a menu-driven computer program that guided clinical assessment, problem
identification, selection of interventions, and measurement of outcomes. Symptom experience was assessed
for 38 symptoms, including frequency, severity, limitations, and level of distress. Interventions were
tailored individually to address up to four symptoms that were prioritised as problems by the participant.
The nurse provided objective information about the management and monitoring of the symptom, but
also provided emotional support and counselling during each session. Control group participants received
any education normally delivered during chemotherapy.
Outcomes The Medical Outcomes Study Short Form (SF-36) was used. The sub-scale vitality was used to measure
fatigue. Other instruments were also used. The Center for Epidemiological Studies Depression-20 scale
and the State-Trait Anxiety Inventory.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes adequate
Ream 2006
Methods RCT. Participants were stratified according to the centre they were treated and the chemotherapy regimen
they were given. 103 participants were randomised, 48 allocated to the intervention, 55 to the control
condition. In the intervention condition 5 participants were lost to follow-up (1 withdrew, 4 declined in
health). In the control condition 12 participants were lost to follow-up (3 withdrew, 9 declined in health).
In both conditions 43 participants were available for analysis. Pre-intervention measurement took place
prior to the chemotherapy. The post-intervention measurement took place prior to the fourth treatment
cycle.
Participants Eligible participants had been diagnosed with, non-Hodgkin’s lymphoma or gastrointestinal, non-small
cell, lung, colorectal, breast, or unknown primary cancer, and were chemotherapy-naive. They had to
understand, speak, read, and write English. Patients were excluded when treated for psychiatric illness. The
mean age of the sample was 56.5 years (18 to 70) and 55% was male. Participants were recruited from the
inpatient or outpatient service prior to commencing their first cycle of treatment.
49Psychosocial interventions for reducing fatigue during cancer treatment in adults (Review)
Copyright © 2009 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Interventions The intervention program was provided by an experienced cancer nurse visiting participants at home,
over the first three treatment cycles (3 sessions). The intervention comprised: assessment/monitoring of
fatigue; education on fatigue including an investigator-designed information pack; coaching in self-care;
and provision of emotional support. Control group received usual care and fatigue assessments.
Outcomes Fatigue (four VAS’), as primary outcome. Other outcomes were Emotional well-being (HADS), General
health status (SF-36) and coping (VAS and COPE).
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes adequate
Sandgren 2000
Methods RCT. Participants first completed baseline questionnaires. For women in the experimental group, telephone therapy
began the week following the return of the questionnaires. Questionnaires were mailed at 1 month (not presented), 4
and 10 month intervals. Data presented came from 53 of the original 62 participants, 24 therapy participants and 29
control participants. Four women failed to complete measures at some intervals, and five dropped out of the study
(one died, others unknown).
Participants Women with stage I or II breast cancer initially were recruited through a tertiary cancer treatment centre serving rural
eastern North Dakota and western Minnesota. Women diagnosed within the prior three to four months were eligible.
All but five women underwent adjuvant treatment, and were in the midst of such treatment during the study. All had
completed chemotherapy and radiation before the 10-month follow-up. Ages ranged from 30 to 82 (mean 51). Nearly
all (92%) of the sample had completed high school, and 30% completed a college education (mean 13.5 years). All
participants were Caucasian except for one Native American.
Interventions Treatment participants received up to 10 telephone calls (mean=9). Therapy was administered once a week for four
weeks and then every other week for six more sessions (4 months). Phone sessions lasted up to 30 minutes, averaging
20 to 25 minutes. Therapy included providing support, teaching coping skills, managing anxiety and stress, and
helping to solve patients-generated problems. Cognitive restructuring was used, a technique that involves identifying
erroneous beliefs, over-generalization, or catastrophic thinking. Therapists also encouraged emotional expression, and
relaxation techniques. Three female clinical psychology master’s candidates conducted the therapy. The control group
had assessments only.
Outcomes The POMS was used to measure distress. It assesses six moods, including fatigue. The Coping Response Indices-
Revised scale was used to measure coping, and the Medical Outcome Scale (MOS) short-form was used to measure
quality of life.
Notes
Sandgren 2003
Methods RCT. Of the 235 participants who began the study 13 dropped out. A total of 222 participants completed the study.
Random assignment to a condition was based on a 2:2:1 ratio. 55 participants in the standard care completed the
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study, 78 of the health education intervention, and 89 of the emotional expression intervention. Participants were
blocked by cancer stage. Measures were collected immediately before the intervention, which was typically after
surgery, but during adjuvant treatment. Follow-up took place approximately 5 months later.
Participants Eligibility criteria included diagnosis of stages I-III breast cancer, ability to speak English and to talk by phone, absence
of serious comorbid conditions, and undergoing adjuvant treatment. Adjuvant treatment included any combination
of chemotherapy, radiotherapy, and hormone therapy. Patients were recruited from two cancer treatment clinics, 1-
3 months after diagnosis. The average age of the sample was 54.5 years, most participants (78%) were married and
Caucasian (97%).
Interventions Both interventions included 5 weekly 30 min phone calls, with a sixth follow-up 3 months later, about the time
adjuvant chemotherapy typically ended. Participants in the health education intervention received a structured
curriculum. The topics included understanding breast cancer and treatment (chemotherapy, radiation therapy, and
hormone therapy), managing post-surgical changes and treatment side effects and fatigue, and maintaining a healthy
lifestyle. Participants in the emotional expression were asked to talk about thoughts, feelings and emotional issues
and stressful experiences. Trained nurses participated in both treatment conditions. Participants in the control group
received standard care in which the usual nurse help line would be available.
Outcomes Outcome measures included quality of life (FACT-B) and additionally POMS. Fatigue was measured as the
fatigue/inertia sub-scale of the POMS.
Notes Not described how many participants were randomised and what was done with any missing values.
Savard 2006
Methods Participants were first stratified according to the cancer clinic they were recruited to. 45 participants were
then randomly assigned either to the CT (25) or WLC (20) condition. Pre-treatment measures were
completed by 21 participants of the CT and 16 of the WLC. Post-treatment measures were completed by
15 (CT) and 13 (WLC). 3-month follow-up measures were completed by 14 (CT) and 10 (WLC). 6-
month follow-up measures were completed by 12 (CT) and 9 (WLC). Reasons for lost to follow-up were,
study or therapy too burdensome, lost interest, due to chemotherapy side effects, terminal stage or death.
Participants Inclusion criteria: 1) a diagnosis of metastatic breast cancer (stage IV) and 2) a score of 7 or more on the
HADS-D or 15 or more on the BDI.
Exclusion criteria: 1) life expectancy of less than 2 months, 2) meeting DSM-IV criteria for a severe
psychiatric disorder other than major depression, 3) presenting severe suicidal ideas with a risk of acting
out, 4) having recently started an antidepressant medication or recently altered the dosage, 5) currently
receiving a psychological intervention targeting depression. Participants were recruited in three cancer
clinics. All participants were Caucasian. In the experimental condition 57% was married, 48% completed
university and the mean age was 51. In the waiting-list control condition 50% were married, 31%
completed university and the mean age was 52. (not described how many participants received treatment).
Interventions Cognitive therapy (CT) was administered individually and involved eight weekly sessions of 60 to 90
minutes, with three booster sessions of CT every 3 weeks following treatment. Two psychologists with
experience in the application of CT conducted the sessions. The ultimate goal was to develop an optimistic
but realistic attitude towards their situation. CT began with the presentation of a cognitive theory of
emotions. Then participants were encouraged to increase their level of daily activities. Participants were
then trained to identify their negative thoughts and to use cognitive restructuring to modify dysfunctional
or irrational cognitions. Participants were then encouraged to redefine their life goals. Finally, future high-
risk situations were identified, as well as strategies to cope with them. Patients in the waiting-list control
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(WLC) condition were scheduled 10 weeks later for CT.
Outcomes Fatigue was measured with the MFI. Other instruments used were Hospital Anxiety and Depression Scale,
Beck Depression Inventory, Insomnia Severity Index, Quality of life questionnaires: QLQ-C33, QLQ BR-
23, and List of Life Events.
Notes
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes not adequate
Spiegel 1981
Methods RCT. 109 women were referred to the study by their oncologists, and 86 completed the first questionnaire. More
participants were randomised to the experimental group (EG=50) than to the control group (CG=36). Of the EG
14 were too weak or too ill to participate and 2 moved away. Of the CG 12 participants were lost; 4 were too ill, 2
died, 4 refused, 2 were out of contact. The final EG consisted of 34 women, and the final CG of 24 women. Follow-
up testing was done at four-month intervals for a total of a year. The analysis considered 16 (EG) and 14 (CG) that
completed all four assessments.
Participants Participants with documented metastatic carcinoma of the breast were included. The average age of the treatment
group was 54 years, and the control group 55 years. 75% of the treatment group and 70% of the control group were
married. Two members of the treatment group and three of the control group lived alone. The average length of time
since diagnosis of recurrence was 54 months for the treatment group and 68 months for the control group. Members
of the treatment and control group received equivalent amounts of chemotherapy during the period of study. At onset
of the study it was noted that the members of the treatment group were of significantly higher social status than were
members of the control group.
Interventions The psychological support groups met weekly in outpatient settings for 1 1/2 hours and were composed of seven to
ten women. Although the period of measurement was one year, no termination time was set for the groups. Three
groups were formed; each group had two leaders, a psychiatrist or a social worker and a counsellor who had had breast
cancer. The groups were designed primarily to be supportive. There was a high degree of cohesion and relatively little
confrontation and here-and-now interpersonal exploration. Interaction in the group often contained a considerable
amount of self disclosure and sharing of mutual fears and concerns. Unlike a therapy group, there were few process
interpretations; the focus was more on content, which included discussion of death and dying, related daily problems,
difficulties in obtaining treatment, issues of communication with physicians, and living as richly as possible in the
face of a terminal illness.
Outcomes Fatigue was measured with the POMS sub-scale fatigue. In addition Health Locus of control, Maladaptive coping
response and denial was measured. Self-esteem was assessed with the Janis-Field Scale and Phobias with a checklist.
Notes No description of the control condition.
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Methods RCT: Baseline assessments were completed at the first treatment visit (week1) (53 of the intervention
group (IG) and 57 of the control group (CG)). The first follow-up assessment (t2) was conducted at the
third course of chemotherapy (CT) (week 7-9) (50 of IG and 54 of CG). The second follow-up (t3)
was conducted at the fourth course of CT or for participants receiving radiotherapy (RT) assessment
was conducted on the first day of RT (week10-13) (50 of IG and 50 of CG). The third follow-up (t4)
was conducted at the fifth course of CT or for participants receiving radiotherapy (RT) assessment was
conducted on the first day of RT. Participants receiving RT at t3, assessment was conducted two weeks
after RT (week 13-21) (49 of IG and 48 of CG).
Participants Women more than 18 years of age with stage I or II breast cancer who were commencing adjuvant
chemotherapy at one of 5 day-treatment units were approached and admitted if they had an ECOG
performance rating of one or two and their haemoglobin level was at least 11.6 g/mL at recruitment.
The mean age of the participants was 49.4, and approximately 65% of the sample had post-high school
qualifications. Most of the women were married (77% in the IG and 73% in the CG).
Interventions The psycho educational intervention, given by an oncology nurse (2), aimed to improve patients knowledge
and skills in performing self-care behaviours to minimize fatigue, based on Green’s PRECEDE model
of health behaviours. Effective strategies to reduce fatigue included promoting: sleep and rest, a balance
between activity and exercise, conserving energy, and restorative activities. The first session, a face to face
contact of 20 minutes, focused on the participants specific needs and to target influencing these factors.
The second and third session, a telephone call of 10 minutes, were aimed to review the patients’ fatigue
management plan, and reinforcement. The intervention was given at the start of the second cycle of
chemotherapy with one week between each session. In addition patients received a booklet with specific
information. Participants in the control group received general cancer education sessions equivalent in
number and timing and also given by the same oncology nurses. The education focused on talking
about general issues associated with living with cancer. Participants also received a booklet with general
information.
Outcomes The primary end points for the study included use of fatigue-management behaviours, confidence with
managing fatigue, and fatigue experiences (levels of fatigue at worst, best, average in the past week and
currently, PFS, and FACT-F).
Notes Not described what was done with missing values.
Risk of bias
Item Authors’ judgement Description
Allocation concealment? Yes adequate
RT: Radiotherapy
vs: versus
CBT: cognitive behavioural therapy
CRF: cancer related fatigue
FOM: fatigue outcome measure
ECAM: energy conservation and activity management
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Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Badger 2005 In a previous study of Badger 2001, participants were randomised between six conditions, five experimental
groups and a control group. In this study participants of the five experimental groups were taken together as
one, and compared with the control group on fatigue. This was not considered to be a RCT.
Bennet 2007 Intervention was conducted after cancer treatment was completed.
Berglund 1994 Intervention was conducted after cancer treatment was completed.
Boesen 2005 Intervention was conducted after cancer treatment was completed.
Burns 2008 No psychosocial intervention. Participants were educated about the use of music imagery and relaxation. Thus
no feedback was given on their behaviour.
Campbell 2005 No psychosocial intervention. The emphasis was placed on exercise.
Campbell 2007 Intervention was conducted after cancer treatment was completed.
Carlson 2005 In this study there was no control or normal care group.
Cimprich 1993 Fatigue was not measured.
Cimprich 2003 Fatigue was not measured.
Clark 2006 No psychosocial intervention. During the intervention participants listened to music, but no feedback was
received on their behaviour.
Cohen 2004 Most participants (71%) did not receive cancer treatment during the intervention.
Courneya 2003 Unclear if participants received cancer treatment during the intervention.
Crooks 2004 Participants were not randomised between the conditions.
Culos-Reed 2006 Intervention was conducted after cancer treatment was completed.
Daley 2004 Intervention was conducted after cancer treatment was completed.
Dalton 2004 Fatigue was not measured.
Dimeo 1999 No psychosocial intervention. The emphasis was placed on exercise.
Dimeo 2004 Intervention was conducted after cancer treatment was completed.
Doorenbos 2005 Fatigue was mentioned as one of the symptoms. Results on the total number of symptoms were described, and
not separated for fatigue.
Fawzy 1990 Cancer participants undergoing treatment were excluded.
Gielissen 2006 The intervention was conducted after cancer treatment was completed.
Given 2004 Fatigue was mentioned as one of the symptoms. Results on the total number of symptoms were described, and
not separated for fatigue.
Given 2005 No psychosocial intervention. The effect of neutropenia was tested.
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(Continued )
Study Reason for exclusion
Haase 2005 No psychosocial intervention. This study evaluated guided imagery and group relaxation. Participants were
provided with tapes and instructions, but no feedback on their behaviour was given.
Hack 2003 Consultation was recorded and participants received an audiotape.
Hanna 2008 In this study there was no control or usual care group.
Hoekstra 2006 No psychosocial intervention. This study evaluated a symptom monitor. Participants monitored their
symptoms, but no additional feedback on their behaviour was provided.
Houborg 2006 Not only cancer participants were included (participants undergoing colorectal surgery also included).
Jacobsen 2002 No psychosocial intervention. This study evaluated two types of stress management consisting of only one
session. This intervention is not a systematic process.
Kim 2002 No psychosocial intervention. In this intervention participants received tapes with information on self-help.
Thus feedback was lacking
Kim 2005 No psychosocial intervention. In this intervention participants received tapes for exercise in bed and relaxation
breathing exercise, but there was no additional feedback.
Korstjens 2008 Intervention was conducted after cancer treatment was finished.
Laidlaw 2005 Less than 10 participants for each condition (n = 7 self hypnosis group, n = 4 Johrei group, n = 3 control group).
Lindemalm 2008 Intervention was conducted after cancer treatment was finished.
Mock 1994 Less than 10 participants for each condition (n = 9 experimental group, n = 5 control group).
Ollenschlager 1992 No psychosocial intervention. The emphasis was placed on changing nutritional behaviour.
Ovesen 1993 Fatigue was not measured.
Oyama 2000 No psychosocial intervention. This study evaluated a Bedside wellness system, including aromatic oil and virtual
reality using sound systems. Thus feedback was lacking.
Persson 2002 Four conditions were described, but participants were randomised between two of the four groups. There was
no control for these two groups..
Post-White 2003 In this study there was no control or normal care group.
Ravasco 2005 No psychosocial intervention. The emphasis was placed on changing nutritional behaviour.
Ravasco 2005a No psychosocial intervention. The emphasis was placed on changing nutritional behaviour.
Roscoe 2005 No psychosocial intervention. This study evaluated polarity, but feedback on their behaviour was lacking.
Savard 2005 Intervention was conducted after cancer treatment was completed.
Sherwood 2005 Fatigue was mentioned as one of the symptoms. Results on the total number of symptoms were described, but
was not separated for fatigue.
Speca 2000 Unclear if participants received cancer treatment during the intervention.
Stanton 2005 Intervention was conducted after cancer treatment was completed.
Stiegelis 2004 Intervention was conducted after cancer treatment was completed.
Strong 2008 Cancer patients with concurrent chemotherapy or radiotherapy were excluded.
Telch 1986 Unclear if participants received cancer treatment during the intervention.
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Vos 2004 Unclear if participants received cancer treatment during the intervention.
Wenzel 1995 Unclear if participants received cancer treatment during the intervention.
Williams 2004 No psychosocial intervention. In this intervention participants were educated using audiotapes. Thus feedback
was lacking.
Williams 2005 No psychosocial intervention. In this intervention participants were educated using audiotapes. Thus feedback
was lacking.
Wydra 2001 No psychosocial intervention. This intervention evaluated self-care management giving participants an
interactive videodisc module, but received no feedback from a care provider.
Characteristics of ongoing studies [ordered by study ID]
Cohen 2004a
Trial name or title Mindfulness relaxation compared with relaxing music and standard symptom management education in
treating patients who are undergoing chemotherapy for newly diagnosed solid tumors.
Methods Randomized phase: Patients are randomized to 1 of 3 treatment arms; Arm I: Patients undergo mindfulness
relaxation therapy (MR); Arm II: Patients listen to relaxing music; Arm III: Patients receive standard symptom
management education. Nausea and vomiting, mental health (anxiety, depression, and distress), and quality of
life (cancer-related symptoms, fatigue, sleep, and pain) are assessed at baseline, in the middle of chemotherapy
(course 2 of a 4-course chemotherapy protocol OR course 3 of a 6-course chemotherapy protocol), at the end
of treatment, and then at 3 months.
Participants Patients who are undergoing chemotherapy for newly diagnosed solid tumors.
Interventions Arm I: Patients undergo mindfulness relaxation (MR) therapy comprising listening to instructions on
breathing techniques and other mind and body relaxation practices on compact disc for 30 minutes before and
during each chemotherapy session and at least once daily for the entire duration of chemotherapy treatment.
Arm II: Patients listen to relaxing music (with no instructions on relaxation techniques) for 30 minutes
before and during each chemotherapy session and at least once daily for the entire duration of chemotherapy
treatment.
Arm III: Patients receive standard symptom management education.
Outcomes Conditioned nausea and vomiting as measured by Morrow assessment of nausea and emesis (MANE);
Distress as measured by Impact of Event Scale (IES); Fatigue as measured by brief fatigue inventory (BFI);
Anxiety as measured by Spielberger State/Trait Anxiety Scale (STAI); Depression as measured by Center
for Epidemiology-Depression (CES-D); Sleep as measured by Pittsburgh Sleep Quality Index (PSQI); Pain
as measured by brief pain inventory (BPI); Quality of life as measured by Functional Assessment of Cancer
Therapy.
Starting date March 2006
Contact information Lorenzo Cohen: U.T.M.D. Anderson Cancer Center USA
Notes
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Cohen 2006
Trial name or title Evaluation of the effect of cognitive behavior intervention on psychological distress of cancer patients and
their family members.
Methods Study Design: Randomized, Active Control Study.
Questionnaires will be answered by the participants pre-, post-intervention and after four months.
Participants Cancer patients.
Interventions Cognitive behavior group intervention.
Outcomes Brief Symptom Inventory, Fatigue inventory, Mini Sleep Questionnaire and repression-sensitization
questionnaire.
Starting date July 2006
Contact information cohenm@research.haifa.ac.il
Notes
Cohen 2007a
Trial name or title Effects of Tibetan yoga on fatigue and sleep in cancer.
Methods Participants are randomly assigned to three groups: a Tibetan Yoga (TY) group; stretching group (SG); or a
usual care group (UC). Measures will be obtained prior to randomization and 1 week, 1 month, 6 months,
and 12 months, after the last intervention session.
Participants Women with breast cancer undergoing chemotherapy.
Interventions Participants in the TY and SG groups will participate in seven weekly group sessions (60 minutes) or 4 sessions
every 3 weeks (90 minutes).
TY: Deep breathing exercises and performing different stretching and movement exercises.
SG: Simple stretching exercises.
Outcomes Fatigue and sleep disturbances.
Starting date November 2006
Contact information Lorenzo Cohen: U.T.M.D. Anderson Cancer Center USA
Notes
Cohen 2007b
Trial name or title Effects of yoga in breast cancer patients.
Methods Participants are randomly assigned to three groups: a Yoga group (YG) group; stretching group (ST); or a
waitlist control group (WL). Measures will be obtained prior to randomization, a brief assessment during the
middle of radiation therapy, during the last week of radiation therapy and 1 month, 3 months, and 6 months,
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Cohen 2007b (Continued )
after the last radiation session.
Participants Women with breast cancer undergoing radiotherapy.
Interventions Participants in the YG and ST groups will attend three sessions (60 minutes) each week throughout their
6-week radiotherapy schedule. TY: Deep breathing exercises and performing different movements and
meditation.
SG: Simple stretching exercises.
Outcomes Fatigue and sleep disturbances (self-report and actigraphy).
Starting date March 2006
Contact information Lorenzo Cohen: U.T.M.D. Anderson Cancer Center USA
Notes
Goedendorp 2005
Trial name or title Evaluation of intervention strategies to manage fatigue during active treatment and to prevent persistent
fatigue after curative treatment for cancer.
Methods Participants are randomly assigned to three groups: the minimal intervention; the CBT intervention; and a
usual care group. Patients will be assessed before cancer treatment (T0), shortly after cancer treatment (at least
6 months after baseline) (T1), and one year after T1.
Participants Patients just have been diagnosed for breast cancer, colorectal cancer, cervix cancer, uterus cancer, testis cancer,
Hodgkin and non-Hodgkin disease. Patients in preparation of receiving therapy with curative intention.
Interventions 1) The nursing intervention consists of a booklet with easily understood general information about two
components. In two one hour session the research nurse will explain the booklet and help the patient to
applicate this to their situation. General information about fatigue during active treatment will be given. The
second component consists of physical activity instructions. In the second session also the adherence of the
patients to the instructions will be discussed.
2) CBT condition will also get and discuss the booklet given in the minimal intervention condition. Additional
they get individual treatment that consists of 10 sessions with a psychotherapist of the Expert Centre Chronic
Fatigue in about six months. Patients will; learn to cope with emotions evoked by having a life-threatening
disease; be thought how to get a more regular sleep/wake cycle; learn to regulate activities; learn to regulate
support of others, emotionally or instrumentally; engaging in activities that give mental rest and relief;
integrate the learned way of thinking and behaving in daily life.
Outcomes Fatigue severity will be measured using the Checklist Individual Strength.
Starting date 1-11-2005
Contact information m.goedendorp@nkcv.umcn.nl; g.bleijenberg@nkcv.umcn.nl
Notes
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Oh 2008b
Trial name or title Randomized Clinical Trial: The impact of medical qigong (traditional Chinese medicine) on fatigue, quality
of life, side effects, mood status and inflammation of cancer patients.
Methods Participants are randomly assigned to two groups: a control group that receive usual health care and an
intervention group who participate in a Medical Qigong (MQ) program in addition to receiving usual health
care at the hospital. Randomisation was stratified by completion of cancer treatment or under active cancer
treatment. Patients completed measures before and after the program.
Participants Patients diagnosed with a range of cancers.
Interventions The 10 week MQ program consists of, coordination of gentle exercise and relaxation through meditation and
breathing exercise based on the Chinese Medicine theory of energy channels.
Outcomes Cancer related fatigue was measured by FACT-F, quality of life and symptoms were measured by the FACT-G,
mood status by POMS. The inflammatory marker serum C-reactive protein (CRP) was also monitored serially.
Starting date Unclear. In September 2008 almost 162 participants were recruited.
Contact information byeongsangoh@health.usyd.edu.au
Notes An abstract can be found at the American Society of Clinical Oncology: 08-AB-32678-ASCOAM
Purcell 2008
Trial name or title A randomised control trial investigating the effects of group education and support in reducing cancer-related
fatigue and improving quality of life in patients undergoing radiotherapy.
Methods Patients will be randomised into one of four group using a 2x2 factorial design. These groups will attend a
fatigue education and support (FES) group either once at the start of treatment, once at the end of treatment
or twice at both the start and end of treatment. These three interventions will be compared to a control group
who receive standard care (no FES group). Patients will be assessed at three time points; once at the start of
treatment, once at the end of treatment, and once six weeks after the completion of treatment.
Participants Patients diagnosed with a range of cancers.
Interventions Participants receive education about radiotherapy process, what to expect from treatment, side effects and
strategies to use to minimise side effects.
Outcomes Fatigue using the Multidimensional Fatigue Inventory.
Starting date 01-04-2008
Contact information Amanda˙purcell@health.qld.gov.au
Notes
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Savard 2008
Trial name or title Self-Help treatment for insomnia in breast cancer patients.
Methods Study Design: Randomized, Active Control Study with three study arms: two forms of cognitive-behavioral
therapy (CBT) and a the control condition (i.e., usual care). Timeframe: pre-treatment, post-treatment, 4
follow-up.
Participants Cancer patients.
Interventions 1: professionally administered cognitive-behavioral therapy, consisting of six weekly sessions.
2: self-administered form of cognitive behavioral therapy, consisting of six short booklets and videotapes.
Outcomes sleep diary indices, actigraphy, Insomnia Severity Index.
Starting date April 2008
Contact information josee.savard@psy.ulaval.ca; julie.villa@crhdq.ulaval.ca
Notes
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D A T A A N D A N A L Y S E S
This review has no analyses.
A P P E N D I C E S
Appendix 1. MEDLINE search strategy
MEDLINE (via OVID)
1. Exp NEOPLASMS
2. BONE MARROW TRANSPLANTATION
3. Exp STEM CELL TRANSPLANTATION
4. (neoplas$ or cancer$ or carcinoma$ or tumour$ or adenocarcinoma$ or leukemi$ or leukaemia$ or lymphoma$ or tumor$ or
malignan$ or melanoma$ or sarcoma$ or “bone marrow transplant$” or “stem cell transplant$”)
5. OR/1-4
6. FATIGUE/
7. (fatigue$ or asthenia or asthenic or astheni$)
8. (exhaustion or exhausted)
9. ((loss adj4 energy) or (loss adj4 vitality))
10. (weary or weariness or weakness)
11. (apathy or apathetic or lassitude or lethargic or lethargy)
12. (sleepy or sleepiness or drowsy or drowsiness)
13. (tired or tiredness)
14. OR/6-13
15. Exp PSYCHOLOGY, SOCIAL/
16. Exp PSYCHOTHERAPY/
17. (psychosocial$ or psycho-social$)
18. (counsel$ or (behaviour$ adj4 therap$) or “autogenic training” or (behavior$ adj4 therap$) or (relax$ adj4 therap$) or (relax$ adj4
treatment$) or (support$ adj4 group$) or imagery or “energy conservation” or “stress management” or psychotherapy$ or “self care”
or “self help” or biofeedback or educati$ or psychoeducat$ or relaxation therap$ or “nursing intervention” or “nursing support”)
19. OR/15-18
20. randomized controlled trial.pt.
21. controlled clinical trial.pt.
22. randomized controlled trials.sh.
23. random allocation.sh.
24. double blind method.sh.
25. single blind method.sh.
26. or/1-6
27. (ANIMALS not HUMANS).sh.
28. 7 not 8
29. clinical trial.pt.
30. Exp CLINICAL TRIALS
31. (clin$ adj25 trial$).ti,ab.
32. ((singl$ or doubl$ or trebl$ or tripl$) adj25 (blind$ or mask$)).ti,ab.
33. placebos.sh.
34. placebo$.ti,ab.
35. random$.ti,ab.
36. research design.sh.
37. or/10-17
38. 18 not 8
39. 19 not 9
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40. 9 or 19
41. 5 AND 14 AND 19 AND 40
H I S T O R Y
Protocol first published: Issue 1, 2008
Review first published: Issue 1, 2009
C O N T R I B U T I O N S O F A U T H O R S
Draft the protocol, develop the search strategy, search for trials, obtain copies of trials: M Goedendorp, M Gielissen, G Bleijenberg
Select which trials to include: M Goedendorp, G Bleijenberg, C Verhagen
Extract data from trials: M Goedendorp, M Gielissen
Enter data into RevMan: M Goedendorp, G Bleijenberg
Carry out the analysis: M Goedendorp
Interpret the analysis: M Goedendorp, M Gielissen, G Bleijenberg and researchers of the ’Expert Centre for Chronic Fatigue’
Draft the final review: M Goedendorp, M Gielissen, G Bleijenberg
Update the review: M Goedendorp, M Gielissen, G Bleijenberg
D E C L A R A T I O N S O F I N T E R E S T
None known
S O U R C E S O F S U P P O R T
Internal sources
• Nijmeegs Kenniscentrum Chronische Vermoeidheid (Expert Centre for Chronic Fatigue), Netherlands.
External sources
• The Dutch Cancer Society, Netherlands.
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